Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3525LS1M
Performance in the last:
Follow this Portfolio
1D 0.3 %
1W -0.1 %
2W 0.8 %
1M 6.2 %
3M 13.0 %
6M 13.4 %
9M -34.9 %
1Y -21.4 %
Alpha
-44.6%
Beta
0.65
sharpe-R
-0.51
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.64
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-12-03 08:17:20
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -47.92%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
CORT Corcept Therapeutics Incorporated Equity Buy 7.83% 18.28%
ITGR Integer Holdings Corporation Equity Buy 18.45% 1.47%
APLS Apellis Pharmaceuticals, Inc. Equity Buy 5.87% 8.55%
MGNX MacroGenics, Inc. Equity Buy 5.87% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Equity Buy 5.96% 0.73%
ESPR Esperion Therapeutics, Inc. Equity Buy 6.71% 0%
CUTR Cutera, Inc. Equity Sell -2.74% 21.43%
AMPH Amphastar Pharmaceuticals, Inc. Equity Sell -4.55% 0.46%
KIDS OrthoPediatrics Corp. Equity Sell -4.69% -0.82%
SEM Select Medical Holdings Corporation Equity Sell -3.77% -3.34%
PACB Pacific Biosciences of California, Inc. Equity Sell -4% -9.66%
IBRX ImmunityBio, Inc. Equity Sell -3.26% 1.39%
FATE Fate Therapeutics, Inc. Equity Sell -3.49% 0%
The percentage of cash held in the portfolio is: 75.83%
** The description of each asset is available Here

The latest 5 Compositions change

2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
CORT Corcept Therapeutics Incorporated Buy 7.83% 18.28%
ITGR Integer Holdings Corporation Buy 18.45% 1.47%
APLS Apellis Pharmaceuticals, Inc. Buy 5.87% 8.55%
MGNX MacroGenics, Inc. Buy 5.87% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.96% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 6.71% 0%
CUTR Cutera, Inc. Sell -2.74% 21.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.55% 0.46%
KIDS OrthoPediatrics Corp. Sell -4.69% -0.82%
SEM Select Medical Holdings Corporation Sell -3.77% -3.34%
PACB Pacific Biosciences of California, Inc. Sell -4% -9.66%
IBRX ImmunityBio, Inc. Sell -3.26% 1.39%
FATE Fate Therapeutics, Inc. Sell -3.49% 0%
The percentage of cash held in the portfolio is: 75.83%
New Assets Added
  • FATE
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-12-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
CORT Corcept Therapeutics Incorporated Buy 7.65% 15.22%
ITGR Integer Holdings Corporation Buy 18.74% 2.73%
APLS Apellis Pharmaceuticals, Inc. Buy 5.64% 3.98%
MGNX MacroGenics, Inc. Buy 5.73% 5.59%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.91% -0.46%
FATE Fate Therapeutics, Inc. Buy 5.93% 0%
CUTR Cutera, Inc. Sell -3.06% 12.5%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.5% 1.95%
KIDS OrthoPediatrics Corp. Sell -4.72% -1.01%
SEM Select Medical Holdings Corporation Sell -3.8% -3.73%
PACB Pacific Biosciences of California, Inc. Sell -3.97% -8.52%
IBRX ImmunityBio, Inc. Sell -3.32% 0%
The percentage of cash held in the portfolio is: 73.76%
New Assets Added
  • IBRX
Assets Removed
Asset Action Perf %
ATEC Sell All 33.5%
Assets Rebalanced
None
2024-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATEC Alphatec Holdings, Inc. Buy 8.33% 32.1%
CORT Corcept Therapeutics Incorporated Buy 7.7% 17.06%
ITGR Integer Holdings Corporation Buy 18.61% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 5.62% 4.63%
MGNX MacroGenics, Inc. Buy 5.75% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.88% 0%
FATE Fate Therapeutics, Inc. Buy 5.88% 0%
CUTR Cutera, Inc. Sell -2.84% 17.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.46% 1.91%
KIDS OrthoPediatrics Corp. Sell -4.57% 1.28%
SEM Select Medical Holdings Corporation Sell -3.63% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.63% 0%
The percentage of cash held in the portfolio is: 61.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All NA
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 6.45% -1.39%
ATEC Alphatec Holdings, Inc. Buy 8.33% 32.1%
CORT Corcept Therapeutics Incorporated Buy 7.7% 17.06%
ITGR Integer Holdings Corporation Buy 18.61% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 5.62% 4.63%
MGNX MacroGenics, Inc. Buy 5.75% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.88% 0%
FATE Fate Therapeutics, Inc. Buy 5.88% 0%
CUTR Cutera, Inc. Sell -2.84% 17.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.46% 1.91%
KIDS OrthoPediatrics Corp. Sell -4.57% 1.28%
SEM Select Medical Holdings Corporation Sell -3.63% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.63% 0%
The percentage of cash held in the portfolio is: 54.91%
New Assets Added
  • SEM
  • PACB
  • ARWR
  • FATE
Assets Removed
Asset Action Perf %
VERU Buy All 13.1%
HCSG Sell All 13.06%
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 7.37% 10.78%
NEOG Neogen Corporation Buy 6.55% -1.19%
ATEC Alphatec Holdings, Inc. Buy 7.82% 22.42%
CORT Corcept Therapeutics Incorporated Buy 7.8% 17.02%
ITGR Integer Holdings Corporation Buy 18.57% 1.48%
APLS Apellis Pharmaceuticals, Inc. Buy 5.44% 0%
MGNX MacroGenics, Inc. Buy 5.44% 0%
VERU Veru Inc. Sell -3.79% 11.9%
CUTR Cutera, Inc. Sell -2.44% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.42% 4.06%
KIDS OrthoPediatrics Corp. Sell -4.72% -0.74%
The percentage of cash held in the portfolio is: 56.39%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 7.04% 6.67%
NEOG Neogen Corporation Buy 6.87% 4.46%
ATEC Alphatec Holdings, Inc. Buy 8.12% 28.15%
CORT Corcept Therapeutics Incorporated Buy 7.6% 14.94%
ITGR Integer Holdings Corporation Buy 18.34% 0.99%
VERU Veru Inc. Sell -3.46% 19.05%
CUTR Cutera, Inc. Sell -1.99% 42.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.5% 1.37%
KIDS OrthoPediatrics Corp. Sell -4.76% -2.41%
The percentage of cash held in the portfolio is: 66.75%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Buy All 15.63%
COLL Buy All 12.68%
CDMO Sell All 18.73%
Assets Rebalanced
None
2024-11-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 8.02% 18.24%
HCSG Healthcare Services Group, Inc. Buy 6.97% 5.21%
NEOG Neogen Corporation Buy 6.71% 1.67%
ATEC Alphatec Holdings, Inc. Buy 8.28% 30.06%
CORT Corcept Therapeutics Incorporated Buy 7.41% 11.71%
ITGR Integer Holdings Corporation Buy 18.12% -0.64%
COLL Collegium Pharmaceutical, Inc. Sell -3.1% 11.37%
VERU Veru Inc. Sell -3.22% 25%
CUTR Cutera, Inc. Sell -2% 42.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.43% 3.34%
KIDS OrthoPediatrics Corp. Sell -4.81% -2.92%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.93% 15.9%
The percentage of cash held in the portfolio is: 65.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTCT Sell All 9.08%
Assets Rebalanced
None
2024-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7% 6.71%
CDMO Avid Bioservices, Inc. Buy 8.02% 17.95%
HCSG Healthcare Services Group, Inc. Buy 6.91% 4.02%
NEOG Neogen Corporation Buy 6.87% 3.91%
ATEC Alphatec Holdings, Inc. Buy 8.06% 26.5%
CORT Corcept Therapeutics Incorporated Buy 7.45% 12.05%
ITGR Integer Holdings Corporation Buy 17.81% -2.48%
COLL Collegium Pharmaceutical, Inc. Sell -3.07% 12.56%
VERU Veru Inc. Sell -3.22% 25%
CUTR Cutera, Inc. Sell -1.88% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.39% 4.34%
KIDS OrthoPediatrics Corp. Sell -4.64% 0.86%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.84% 17.98%
The percentage of cash held in the portfolio is: 58.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Buy All 1.47%
IRTC Sell All -9.45%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.58% 0.1%
CDMO Avid Bioservices, Inc. Buy 8.02% 17.66%
HCSG Healthcare Services Group, Inc. Buy 6.9% 3.74%
NEOG Neogen Corporation Buy 6.98% 5.23%
ATEC Alphatec Holdings, Inc. Buy 7.79% 21.91%
CORT Corcept Therapeutics Incorporated Buy 7.23% 8.49%
IRTC iRhythm Technologies, Inc. Buy 6.09% -7.33%
ITGR Integer Holdings Corporation Buy 17.88% -2.37%
COLL Collegium Pharmaceutical, Inc. Sell -3.05% 13.29%
VERU Veru Inc. Sell -3.23% 25%
CUTR Cutera, Inc. Sell -1.88% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.36% 5.36%
TNDM Tandem Diabetes Care, Inc. Sell -4.27% 8.92%
KIDS OrthoPediatrics Corp. Sell -4.43% 5.44%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.99% 14.91%
The percentage of cash held in the portfolio is: 57.74%
New Assets Added
None
Assets Removed
Asset Action Perf %
INCY Sell All -4.56%
MGNX Sell All -10.08%
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.57% -0.23%
CDMO Avid Bioservices, Inc. Buy 7.99% 17.18%
HCSG Healthcare Services Group, Inc. Buy 7.02% 5.39%
NEOG Neogen Corporation Buy 6.76% 1.81%
INCY Incyte Corporation Buy 6.78% 2.62%
ATEC Alphatec Holdings, Inc. Buy 6.71% 4.84%
MGNX MacroGenics, Inc. Buy 6.16% -7.75%
CORT Corcept Therapeutics Incorporated Buy 6.91% 3.54%
IRTC iRhythm Technologies, Inc. Buy 6.5% -1.22%
ITGR Integer Holdings Corporation Buy 17.85% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.63% -5.24%
COLL Collegium Pharmaceutical, Inc. Sell -3.03% 13.79%
VERU Veru Inc. Sell -2.98% 30.95%
CUTR Cutera, Inc. Sell -2.01% 42.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.46% 3.21%
TNDM Tandem Diabetes Care, Inc. Sell -4.19% 10.65%
KIDS OrthoPediatrics Corp. Sell -4.18% 10.85%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.04% 13.91%
The percentage of cash held in the portfolio is: 38.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
BHVN Buy All 13.76%
RGEN Sell All -17.11%
VREX Sell All 13.22%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 7.06% 12.89%
PTCT PTC Therapeutics, Inc. Buy 6.94% 7.78%
CDMO Avid Bioservices, Inc. Buy 7.69% 15.15%
HCSG Healthcare Services Group, Inc. Buy 7.1% 8.95%
NEOG Neogen Corporation Buy 6.63% 2.09%
INCY Incyte Corporation Buy 6.79% 5.14%
ATEC Alphatec Holdings, Inc. Buy 6.96% 11.21%
MGNX MacroGenics, Inc. Buy 6.43% -1.55%
CORT Corcept Therapeutics Incorporated Buy 7.15% 9.45%
IRTC iRhythm Technologies, Inc. Buy 6.59% 2.46%
ITGR Integer Holdings Corporation Buy 17.69% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.57% -3.91%
RGEN Repligen Corporation Buy 5.83% -5.34%
BHVN Biohaven Ltd. Sell -3.18% 5.46%
COLL Collegium Pharmaceutical, Inc. Sell -3.04% 11.77%
VERU Veru Inc. Sell -3.17% 25%
CUTR Cutera, Inc. Sell -2.03% 41.07%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.41% 2.23%
TNDM Tandem Diabetes Care, Inc. Sell -4.29% 6.57%
KIDS OrthoPediatrics Corp. Sell -4.05% 11.78%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.2% 8.49%
The percentage of cash held in the portfolio is: 27.93%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 26.23%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 6.97% 15.04%
PTCT PTC Therapeutics, Inc. Buy 6.99% 11.98%
NUTX Nutex Health Inc. Buy 8.23% 31.39%
CDMO Avid Bioservices, Inc. Buy 7.62% 17.76%
HCSG Healthcare Services Group, Inc. Buy 7.04% 11.32%
NEOG Neogen Corporation Buy 6.66% 5.86%
INCY Incyte Corporation Buy 6.82% 8.86%
ATEC Alphatec Holdings, Inc. Buy 7.06% 16.31%
MGNX MacroGenics, Inc. Buy 6.17% -2.58%
CORT Corcept Therapeutics Incorporated Buy 7.14% 12.76%
IRTC iRhythm Technologies, Inc. Buy 6.68% 6.99%
ITGR Integer Holdings Corporation Buy 17.49% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.57% -0.89%
ALT Altimmune, Inc. Buy 5.89% 0.32%
RGEN Repligen Corporation Buy 5.97% 0%
BHVN Biohaven Ltd. Sell -3.1% 4.72%
COLL Collegium Pharmaceutical, Inc. Sell -2.94% 12.04%
VERU Veru Inc. Sell -3.02% 26.19%
CUTR Cutera, Inc. Sell -2.14% 35.71%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.32% 1.32%
TNDM Tandem Diabetes Care, Inc. Sell -4.32% 3.04%
KIDS OrthoPediatrics Corp. Sell -4.2% 5.68%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.2% 5.78%
The percentage of cash held in the portfolio is: 13.94%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
CARA Sell All -6.09%
ARWR Sell All 11.73%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.2% 11.11%
VREX Varex Imaging Corporation Buy 7.05% 18.26%
PTCT PTC Therapeutics, Inc. Buy 6.97% 13.48%
NUTX Nutex Health Inc. Buy 9.32% 51.33%
CDMO Avid Bioservices, Inc. Buy 7.51% 18.05%
HCSG Healthcare Services Group, Inc. Buy 7.06% 13.61%
NEOG Neogen Corporation Buy 6.62% 6.97%
INCY Incyte Corporation Buy 6.71% 8.99%
ATEC Alphatec Holdings, Inc. Buy 7.06% 18.22%
MGNX MacroGenics, Inc. Buy 6.6% 5.94%
CORT Corcept Therapeutics Incorporated Buy 7.19% 15.44%
IRTC iRhythm Technologies, Inc. Buy 6.57% 7.07%
CARA Cara Therapeutics, Inc. Buy 5.86% -1.16%
ITGR Integer Holdings Corporation Buy 17.12% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.42% -1.24%
ALT Altimmune, Inc. Buy 5.77% 0%
BHVN Biohaven Ltd. Sell -3.13% 2.16%
COLL Collegium Pharmaceutical, Inc. Sell -3.01% 8.45%
VERU Veru Inc. Sell -3.16% 21.43%
CUTR Cutera, Inc. Sell -2.28% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.45% -3.51%
TNDM Tandem Diabetes Care, Inc. Sell -4.45% -1.63%
KIDS OrthoPediatrics Corp. Sell -4.09% 6.53%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.22% 3.7%
The percentage of cash held in the portfolio is: 7.77%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
IBRX Sell All 17.58%
IOVA Sell All -12.15%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.32% 13.48%
VREX Varex Imaging Corporation Buy 7.19% 20.74%
PTCT PTC Therapeutics, Inc. Buy 7% 14.11%
NUTX Nutex Health Inc. Buy 6.92% 12.45%
CDMO Avid Bioservices, Inc. Buy 7.51% 18.24%
IBRX ImmunityBio, Inc. Buy 6.77% 29.45%
HCSG Healthcare Services Group, Inc. Buy 6.92% 11.51%
IOVA Iovance Biotherapeutics, Inc. Buy 5.91% -3.45%
NEOG Neogen Corporation Buy 7.07% 14.37%
INCY Incyte Corporation Buy 6.78% 10.28%
ATEC Alphatec Holdings, Inc. Buy 7.36% 23.57%
MGNX MacroGenics, Inc. Buy 7.06% 13.44%
CORT Corcept Therapeutics Incorporated Buy 7.33% 17.98%
IRTC iRhythm Technologies, Inc. Buy 6.69% 9.2%
CARA Cara Therapeutics, Inc. Buy 5.85% -1.16%
ITGR Integer Holdings Corporation Buy 17.42% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 7.5% 0%
BHVN Biohaven Ltd. Sell -3.26% -1.87%
COLL Collegium Pharmaceutical, Inc. Sell -3.08% 6.21%
VERU Veru Inc. Sell -3.44% 14.29%
CUTR Cutera, Inc. Sell -2.28% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.53% -5.38%
TNDM Tandem Diabetes Care, Inc. Sell -4.48% -2.52%
KIDS OrthoPediatrics Corp. Sell -4.25% 2.88%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.29% 1.81%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
Asset Action Perf %
VCEL Sell All 34.9%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 7.2% 28.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.34% 13.07%
VREX Varex Imaging Corporation Buy 7.05% 17.52%
PTCT PTC Therapeutics, Inc. Buy 6.95% 12.61%
NUTX Nutex Health Inc. Buy 7.88% 27.16%
CDMO Avid Bioservices, Inc. Buy 7.57% 18.34%
IBRX ImmunityBio, Inc. Buy 6.97% 32.3%
HCSG Healthcare Services Group, Inc. Buy 6.78% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 5.92% -3.99%
NEOG Neogen Corporation Buy 7.05% 13.18%
INCY Incyte Corporation Buy 6.99% 12.78%
ATEC Alphatec Holdings, Inc. Buy 7.19% 19.75%
MGNX MacroGenics, Inc. Buy 7.04% 12.4%
CORT Corcept Therapeutics Incorporated Buy 7.45% 19.06%
IRTC iRhythm Technologies, Inc. Buy 6.55% 6.19%
CARA Cara Therapeutics, Inc. Buy 5.88% -1.45%
ITGR Integer Holdings Corporation Buy 17.2% 0%
BHVN Biohaven Ltd. Sell -3.35% -3.89%
COLL Collegium Pharmaceutical, Inc. Sell -3.1% 6.27%
VERU Veru Inc. Sell -3.52% 13.1%
CUTR Cutera, Inc. Sell -2.3% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.53% -4.82%
TNDM Tandem Diabetes Care, Inc. Sell -4.4% 0%
KIDS OrthoPediatrics Corp. Sell -4.4% 0%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.4% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TNDM
  • KIDS
  • ENTA
  • ITGR
Assets Removed
Asset Action Perf %
EVH Buy All 42.39%
ARDX Sell All -16.06%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 7.42% 5.63%
VCEL Vericel Corporation Buy 6.82% 18.86%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.34% 10.49%
VREX Varex Imaging Corporation Buy 7.23% 17.93%
PTCT PTC Therapeutics, Inc. Buy 6.9% 9.26%
NUTX Nutex Health Inc. Buy 7.37% 16.4%
CDMO Avid Bioservices, Inc. Buy 7.73% 18.15%
IBRX ImmunityBio, Inc. Buy 6.78% 25.89%
HCSG Healthcare Services Group, Inc. Buy 6.86% 7.31%
IOVA Iovance Biotherapeutics, Inc. Buy 7.01% 11.33%
NEOG Neogen Corporation Buy 7% 10.04%
INCY Incyte Corporation Buy 7.05% 11.38%
ATEC Alphatec Holdings, Inc. Buy 7.36% 19.87%
MGNX MacroGenics, Inc. Buy 7.38% 15.25%
CORT Corcept Therapeutics Incorporated Buy 6.94% 8.47%
IRTC iRhythm Technologies, Inc. Buy 6.88% 8.99%
CARA Cara Therapeutics, Inc. Buy 6.1% 0%
BHVN Biohaven Ltd. Sell -3.4% -3.15%
EVH Evolent Health, Inc. Sell -3.26% -5.95%
COLL Collegium Pharmaceutical, Inc. Sell -3.42% -1.17%
VERU Veru Inc. Sell -3.6% 13.1%
CUTR Cutera, Inc. Sell -3.07% 8.93%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.42% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMPH
  • CARA
Assets Removed
Asset Action Perf %
CHRS Buy All -13.57%
NVRO Sell All -1.11%
Assets Rebalanced
None
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 7.66% 7.45%
VCEL Vericel Corporation Buy 6.65% 14.14%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.42% 10.23%
VREX Varex Imaging Corporation Buy 7.44% 19.42%
PTCT PTC Therapeutics, Inc. Buy 7.04% 9.82%
NUTX Nutex Health Inc. Buy 7.04% 9.47%
CDMO Avid Bioservices, Inc. Buy 7.04% 5.98%
IBRX ImmunityBio, Inc. Buy 7.04% 28.74%
HCSG Healthcare Services Group, Inc. Buy 7.04% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 7.04% 10.06%
NEOG Neogen Corporation Buy 7.04% 8.93%
NVRO Nevro Corp. Buy 7.04% 7.04%
INCY Incyte Corporation Buy 7.04% 9.5%
ATEC Alphatec Holdings, Inc. Buy 7.04% 12.99%
MGNX MacroGenics, Inc. Buy 7.04% 8.27%
CORT Corcept Therapeutics Incorporated Buy 7.04% 8.33%
IRTC iRhythm Technologies, Inc. Buy 7.04% 9.9%
BHVN Biohaven Ltd. Sell -3.49% -4.41%
EVH Evolent Health, Inc. Sell -3.34% -6.81%
COLL Collegium Pharmaceutical, Inc. Sell -3.45% -0.55%
CHRS Coherus BioSciences, Inc. Sell -4.22% -0.28%
VERU Veru Inc. Sell -3.7% 11.9%
CUTR Cutera, Inc. Sell -3.55% -3.57%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All -11.47%
Assets Rebalanced
Asset Action Weight
CORT Sell -0.71%
IRTC Sell -0.82%
NVRO Sell -1.11%
INCY Sell -1.3%
ATEC Sell -1.61%
IBRX Sell -1.63%
NEOG Sell -1.83%
HCSG Sell -3.62%
IOVA Sell -3.78%
VREX Buy 0.55%
ARDX Buy 0.78%
PTCT Buy 1.12%
NUTX Buy 1.14%
CDMO Buy 1.35%
MGNX Buy 6.49%
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.15% -2.48%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.54% 3.62%
VCEL Vericel Corporation Buy 6.65% 5.42%
VREX Varex Imaging Corporation Buy 6.44% 9.5%
NUTX Nutex Health Inc. Buy 5.42% -7.17%
PTCT PTC Therapeutics, Inc. Buy 6% 2.72%
CDMO Avid Bioservices, Inc. Buy 5.8% -0.19%
IBRX ImmunityBio, Inc. Buy 9.01% 23.52%
HCSG Healthcare Services Group, Inc. Buy 10.86% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 11.04% 3.72%
NEOG Neogen Corporation Buy 8.88% 0.63%
NVRO Nevro Corp. Buy 8.17% -0.93%
INCY Incyte Corporation Buy 8.45% 2.46%
ATEC Alphatec Holdings, Inc. Buy 8.83% 6.5%
MGNX MacroGenics, Inc. Buy 0.53% -4.39%
IRTC iRhythm Technologies, Inc. Buy 7.75% 0%
CORT Corcept Therapeutics Incorporated Buy 7.75% 0%
BHVN Biohaven Ltd. Sell -3.52% 2.78%
EVH Evolent Health, Inc. Sell -3.41% -0.73%
SMTI Sanara MedTech Inc. Sell -3.94% -6.02%
COLL Collegium Pharmaceutical, Inc. Sell -3.54% 4.63%
CHRS Coherus BioSciences, Inc. Sell -4.22% 7.2%
VERU Veru Inc. Sell -3.96% 13.1%
CUTR Cutera, Inc. Sell -3.71% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CUTR
  • IRTC
  • CORT
Assets Removed
Asset Action Perf %
AXSM Sell All -6.53%
VKTX Sell All -13.77%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.35% 0.83%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.34% 0.67%
VCEL Vericel Corporation Buy 6.58% 4.51%
VREX Varex Imaging Corporation Buy 6.41% 9.09%
AXSM Axsome Therapeutics, Inc. Buy 5.59% -4.83%
NUTX Nutex Health Inc. Buy 5.31% -8.94%
PTCT PTC Therapeutics, Inc. Buy 6% 2.92%
CDMO Avid Bioservices, Inc. Buy 5.75% -0.87%
VKTX Viking Therapeutics, Inc. Buy 7.25% -0.46%
IBRX ImmunityBio, Inc. Buy 9.14% 25.42%
HCSG Healthcare Services Group, Inc. Buy 10.82% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 10.78% 1.45%
NEOG Neogen Corporation Buy 8.87% 0.7%
NVRO Nevro Corp. Buy 8.43% 2.41%
INCY Incyte Corporation Buy 8.48% 2.98%
ATEC Alphatec Holdings, Inc. Buy 8.55% 3.31%
MGNX MacroGenics, Inc. Buy 0.56% 0%
BHVN Biohaven Ltd. Sell -3.58% 1.15%
EVH Evolent Health, Inc. Sell -3.42% -1.16%
SMTI Sanara MedTech Inc. Sell -3.94% -6.21%
COLL Collegium Pharmaceutical, Inc. Sell -3.61% 2.48%
CHRS Coherus BioSciences, Inc. Sell -4.55% -0.14%
VERU Veru Inc. Sell -4.11% 9.52%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
CUTR Buy All 21.33%
FATE Buy All 24.3%
IRWD Sell All -1.64%
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.8% -7.28%
ARDX Ardelyx, Inc. Buy 6.29% -2.81%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.42% -0.67%
VCEL Vericel Corporation Buy 6.77% 4.63%
VREX Varex Imaging Corporation Buy 6.54% 8.51%
AXSM Axsome Therapeutics, Inc. Buy 5.75% -4.63%
NUTX Nutex Health Inc. Buy 5.38% -10.19%
PTCT PTC Therapeutics, Inc. Buy 6.08% 1.53%
CDMO Avid Bioservices, Inc. Buy 5.73% -3.86%
VKTX Viking Therapeutics, Inc. Buy 7.41% -0.93%
IBRX ImmunityBio, Inc. Buy 9.26% 23.75%
HCSG Healthcare Services Group, Inc. Buy 10.93% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 10.33% -5.35%
NEOG Neogen Corporation Buy 9.01% -0.42%
NVRO Nevro Corp. Buy 8.63% 2.04%
INCY Incyte Corporation Buy 8.48% 0.26%
ATEC Alphatec Holdings, Inc. Buy 8.5% 0%
CUTR Cutera, Inc. Sell -2.77% 22.67%
FATE Fate Therapeutics, Inc. Sell -2.64% 26.17%
BHVN Biohaven Ltd. Sell -3.59% 3.32%
EVH Evolent Health, Inc. Sell -3.49% -0.69%
SMTI Sanara MedTech Inc. Sell -3.98% -4.6%
COLL Collegium Pharmaceutical, Inc. Sell -3.79% 0.5%
CHRS Coherus BioSciences, Inc. Sell -4.81% -3.19%
VERU Veru Inc. Sell -4.22% 9.52%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ATEC
Assets Removed
None
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.97% -2.58%
ARDX Ardelyx, Inc. Buy 6.18% -2.48%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.45% 1.81%
VCEL Vericel Corporation Buy 6.86% 8.2%
VREX Varex Imaging Corporation Buy 6.52% 10.33%
AXSM Axsome Therapeutics, Inc. Buy 5.67% -4.17%
NUTX Nutex Health Inc. Buy 5.57% -5.16%
PTCT PTC Therapeutics, Inc. Buy 6.07% 3.41%
CDMO Avid Bioservices, Inc. Buy 5.72% -2.03%
VKTX Viking Therapeutics, Inc. Buy 7.19% -2.01%
IBRX ImmunityBio, Inc. Buy 9.82% 33.97%
HCSG Healthcare Services Group, Inc. Buy 10.8% 0.91%
IOVA Iovance Biotherapeutics, Inc. Buy 10.71% 0.09%
NEOG Neogen Corporation Buy 9.01% 1.6%
NVRO Nevro Corp. Buy 8.29% 0%
INCY Incyte Corporation Buy 8.29% 0%
CUTR Cutera, Inc. Sell -3% 14.67%
FATE Fate Therapeutics, Inc. Sell -2.72% 22.43%
BHVN Biohaven Ltd. Sell -3.57% 1.96%
EVH Evolent Health, Inc. Sell -3.54% -4.1%
SMTI Sanara MedTech Inc. Sell -3.87% -3.8%
COLL Collegium Pharmaceutical, Inc. Sell -3.77% -1.05%
CHRS Coherus BioSciences, Inc. Sell -4.75% -3.88%
VERU Veru Inc. Sell -4.19% 8.33%
The percentage of cash held in the portfolio is: 10.29%
New Assets Added
  • NVRO
  • INCY
Assets Removed
Asset Action Perf %
ALGN Sell All -2.57%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.14% -0.23%
ARDX Ardelyx, Inc. Buy 6.33% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.56% 3.2%
VCEL Vericel Corporation Buy 6.92% 8.89%
VREX Varex Imaging Corporation Buy 6.52% 10%
AXSM Axsome Therapeutics, Inc. Buy 5.74% -3.21%
NUTX Nutex Health Inc. Buy 5.24% -10.96%
PTCT PTC Therapeutics, Inc. Buy 6.36% 8.09%
CDMO Avid Bioservices, Inc. Buy 5.75% -1.74%
ALGN Align Technology, Inc. Buy 7.23% -1.68%
VKTX Viking Therapeutics, Inc. Buy 7.37% 0.18%
IBRX ImmunityBio, Inc. Buy 9.8% 33.25%
HCSG Healthcare Services Group, Inc. Buy 10.79% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 10.51% -1.99%
NEOG Neogen Corporation Buy 8.89% 0%
CUTR Cutera, Inc. Sell -3.14% 10.67%
FATE Fate Therapeutics, Inc. Sell -2.98% 15.26%
BHVN Biohaven Ltd. Sell -3.61% 1.01%
EVH Evolent Health, Inc. Sell -3.42% -0.34%
SMTI Sanara MedTech Inc. Sell -3.84% -2.69%
COLL Collegium Pharmaceutical, Inc. Sell -3.84% -2.71%
CHRS Coherus BioSciences, Inc. Sell -4.72% -2.91%
VERU Veru Inc. Sell -4.37% 4.76%
The percentage of cash held in the portfolio is: 19.78%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.93% -2.58%
ARDX Ardelyx, Inc. Buy 6.14% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.55% 4.24%
VCEL Vericel Corporation Buy 6.82% 8.48%
VREX Varex Imaging Corporation Buy 6.37% 8.68%
NKTR Nektar Therapeutics Buy 5.5% -6.21%
AXSM Axsome Therapeutics, Inc. Buy 5.66% -3.47%
NUTX Nutex Health Inc. Buy 5.63% -3.3%
PTCT PTC Therapeutics, Inc. Buy 5.99% 2.95%
CDMO Avid Bioservices, Inc. Buy 5.65% -2.51%
ALGN Align Technology, Inc. Buy 7.25% -0.29%
VKTX Viking Therapeutics, Inc. Buy 7.4% 1.78%
IBRX ImmunityBio, Inc. Buy 10.66% 46.56%
HCSG Healthcare Services Group, Inc. Buy 10.61% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 10.61% 0%
CUTR Cutera, Inc. Sell -3.11% 10.67%
FATE Fate Therapeutics, Inc. Sell -3.11% 10.59%
BHVN Biohaven Ltd. Sell -3.63% -0.54%
EVH Evolent Health, Inc. Sell -3.43% -1.81%
SMTI Sanara MedTech Inc. Sell -3.85% -4.15%
COLL Collegium Pharmaceutical, Inc. Sell -3.79% -2.39%
CHRS Coherus BioSciences, Inc. Sell -4.54% 0%
VERU Veru Inc. Sell -4.54% 0%
The percentage of cash held in the portfolio is: 23.22%
New Assets Added
  • CHRS
  • VERU
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.95% -7.04%
ARDX Ardelyx, Inc. Buy 6.33% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.87% 3.82%
VCEL Vericel Corporation Buy 6.88% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 10.24% 54.64%
VREX Varex Imaging Corporation Buy 6.59% 6.69%
NKTR Nektar Therapeutics Buy 5.62% -8.97%
AXSM Axsome Therapeutics, Inc. Buy 5.94% -3.73%
NUTX Nutex Health Inc. Buy 6% -2.14%
PTCT PTC Therapeutics, Inc. Buy 6.35% 3.64%
CDMO Avid Bioservices, Inc. Buy 5.89% -3.47%
ALGN Align Technology, Inc. Buy 7.76% 1.33%
VKTX Viking Therapeutics, Inc. Buy 8.16% 6.57%
IBRX ImmunityBio, Inc. Buy 9.68% 26.37%
CUTR Cutera, Inc. Sell -3.13% 14.67%
FATE Fate Therapeutics, Inc. Sell -3.03% 17.45%
BHVN Biohaven Ltd. Sell -3.9% -2.66%
EVH Evolent Health, Inc. Sell -3.68% -3.58%
SMTI Sanara MedTech Inc. Sell -3.92% -0.48%
COLL Collegium Pharmaceutical, Inc. Sell -3.94% -1.14%
The percentage of cash held in the portfolio is: 23.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.12% -6.57%
ORGO Organogenesis Holdings Inc. Buy 6.34% -6.82%
ARDX Ardelyx, Inc. Buy 6.57% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.97% 2.94%
VCEL Vericel Corporation Buy 6.9% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 10.4% 53.61%
VREX Varex Imaging Corporation Buy 6.69% 5.95%
NKTR Nektar Therapeutics Buy 5.88% -6.9%
AXSM Axsome Therapeutics, Inc. Buy 6.01% -4.84%
NUTX Nutex Health Inc. Buy 6.21% -0.97%
PTCT PTC Therapeutics, Inc. Buy 6.6% 5.29%
CDMO Avid Bioservices, Inc. Buy 6.15% -1.45%
ALGN Align Technology, Inc. Buy 7.83% 0%
VKTX Viking Therapeutics, Inc. Buy 7.83% 0%
IBRX ImmunityBio, Inc. Buy 7.83% 0%
CUTR Cutera, Inc. Sell -3.25% 13.33%
FATE Fate Therapeutics, Inc. Sell -3.28% 12.46%
BHVN Biohaven Ltd. Sell -3.96% -1.73%
EVH Evolent Health, Inc. Sell -3.57% 1.81%
SMTI Sanara MedTech Inc. Sell -3.99% 0%
COLL Collegium Pharmaceutical, Inc. Sell -3.99% 0%
The percentage of cash held in the portfolio is: 17.67%
New Assets Added
  • SMTI
  • COLL
  • ALGN
  • VKTX
  • IBRX
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.11% -6.57%
ORGO Organogenesis Holdings Inc. Buy 6.37% -6.17%
ARDX Ardelyx, Inc. Buy 6.25% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.96% 2.89%
VCEL Vericel Corporation Buy 6.79% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 10.73% 58.76%
VREX Varex Imaging Corporation Buy 6.64% 5.37%
NKTR Nektar Therapeutics Buy 6.13% -2.76%
AXSM Axsome Therapeutics, Inc. Buy 6.24% -1.1%
NUTX Nutex Health Inc. Buy 5.95% -4.88%
PTCT PTC Therapeutics, Inc. Buy 6.76% 8.04%
CDMO Avid Bioservices, Inc. Buy 6.23% 0%
CUTR Cutera, Inc. Sell -3.29% 12%
FATE Fate Therapeutics, Inc. Sell -3.53% 5.61%
BHVN Biohaven Ltd. Sell -3.98% -2.49%
EVH Evolent Health, Inc. Sell -3.5% 3.41%
The percentage of cash held in the portfolio is: 33.14%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.36% -4.23%
ORGO Organogenesis Holdings Inc. Buy 6.94% 0.65%
ARDX Ardelyx, Inc. Buy 6.57% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.23% 5.27%
VCEL Vericel Corporation Buy 6.82% -0.62%
CDXS Codexis, Inc. Buy 6.68% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 8.56% 24.74%
VREX Varex Imaging Corporation Buy 6.64% 3.64%
NKTR Nektar Therapeutics Buy 6.36% -0.69%
AXSM Axsome Therapeutics, Inc. Buy 6.34% -1.02%
NUTX Nutex Health Inc. Buy 6.36% 0%
PTCT PTC Therapeutics, Inc. Buy 6.36% 0%
CUTR Cutera, Inc. Sell -3.54% 6.8%
FATE Fate Therapeutics, Inc. Sell -3.78% 0.62%
BHVN Biohaven Ltd. Sell -4.03% -2.29%
EVH Evolent Health, Inc. Sell -3.64% 0.99%
The percentage of cash held in the portfolio is: 33.78%
New Assets Added
  • NUTX
  • PTCT
Assets Removed
Asset Action Perf %
IRTC Buy All -20.54%
LXRX Sell All -3.48%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.61% -1.64%
ORGO Organogenesis Holdings Inc. Buy 7.05% 0.97%
ARDX Ardelyx, Inc. Buy 6.77% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.36% 5.84%
VCEL Vericel Corporation Buy 6.8% -2.16%
CDXS Codexis, Inc. Buy 6.74% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 6.52% -6.19%
VREX Varex Imaging Corporation Buy 6.75% 4.13%
NKTR Nektar Therapeutics Buy 6.21% -4.14%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.29% -2.99%
AXSM Axsome Therapeutics, Inc. Buy 6.35% -1.98%
CUTR Cutera, Inc. Sell -3.59% 6.67%
FATE Fate Therapeutics, Inc. Sell -3.78% 1.87%
IRTC iRhythm Technologies, Inc. Sell -3.75% 0.97%
BHVN Biohaven Ltd. Sell -3.98% 0.25%
EVH Evolent Health, Inc. Sell -3.73% 0%
The percentage of cash held in the portfolio is: 45.38%
New Assets Added
  • EVH
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.91% 4.23%
ORGO Organogenesis Holdings Inc. Buy 6.86% -0.32%
ARDX Ardelyx, Inc. Buy 6.61% -3.48%
BKD Brookdale Senior Living Inc. Buy 7.49% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.38% 7.64%
VCEL Vericel Corporation Buy 6.62% -3.37%
CDXS Codexis, Inc. Buy 6.81% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 6.64% -3.09%
VREX Varex Imaging Corporation Buy 6.39% 0%
NKTR Nektar Therapeutics Buy 6.39% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.39% 0%
AXSM Axsome Therapeutics, Inc. Buy 6.39% 0%
CUTR Cutera, Inc. Sell -3.34% 12%
FATE Fate Therapeutics, Inc. Sell -3.8% -0.31%
IRTC iRhythm Technologies, Inc. Sell -3.72% 0.35%
BHVN Biohaven Ltd. Sell -3.95% -0.33%
The percentage of cash held in the portfolio is: 33.95%
New Assets Added
  • VREX
  • NKTR
  • LXRX
  • AXSM
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.88% 5.63%
ORGO Organogenesis Holdings Inc. Buy 7.13% 5.52%
ARDX Ardelyx, Inc. Buy 6.52% -3.15%
BKD Brookdale Senior Living Inc. Buy 7.43% 10.41%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.34% 8.99%
VCEL Vericel Corporation Buy 6.6% -1.95%
RDNT RadNet, Inc. Buy 6.71% -0.34%
CDXS Codexis, Inc. Buy 6.99% 3.83%
SGMO Sangamo Therapeutics, Inc. Buy 6.88% 2.27%
CUTR Cutera, Inc. Sell -3.38% 9.25%
FATE Fate Therapeutics, Inc. Sell -3.73% 0%
IRTC iRhythm Technologies, Inc. Sell -3.61% 1.5%
AXSM Axsome Therapeutics, Inc. Sell -3.81% -3.9%
BHVN Biohaven Ltd. Sell -3.87% 0%
The percentage of cash held in the portfolio is: 55.91%
New Assets Added
  • BHVN
Assets Removed
Asset Action Perf %
ORMP Buy All -1.67%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.78% 3.05%
ORGO Organogenesis Holdings Inc. Buy 7.09% 3.9%
ARDX Ardelyx, Inc. Buy 6.72% -1.16%
BKD Brookdale Senior Living Inc. Buy 6.82% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.98% 2.69%
VCEL Vericel Corporation Buy 6.78% -0.33%
RDNT RadNet, Inc. Buy 6.81% 0.2%
CDXS Codexis, Inc. Buy 6.8% 0%
SGMO Sangamo Therapeutics, Inc. Buy 6.8% 0%
CUTR Cutera, Inc. Sell -3.46% 8%
FATE Fate Therapeutics, Inc. Sell -3.58% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.7% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.55% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -3.7% 0.18%
The percentage of cash held in the portfolio is: 56.4%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.66% 0.7%
ORGO Organogenesis Holdings Inc. Buy 6.89% 0.32%
ARDX Ardelyx, Inc. Buy 6.78% -0.83%
BKD Brookdale Senior Living Inc. Buy 6.84% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.84% 0%
VCEL Vericel Corporation Buy 6.84% 0%
RDNT RadNet, Inc. Buy 6.84% 0%
CUTR Cutera, Inc. Sell -3.58% 5.33%
FATE Fate Therapeutics, Inc. Sell -3.6% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.77% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.44% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -3.68% 1.35%
The percentage of cash held in the portfolio is: 70.38%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.64% 0%
ORGO Organogenesis Holdings Inc. Buy 6.87% -0.32%
ARDX Ardelyx, Inc. Buy 6.86% 0%
CUTR Cutera, Inc. Sell -3.85% -1.33%
FATE Fate Therapeutics, Inc. Sell -3.66% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -3.78% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.4% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -3.78% -1.12%
The percentage of cash held in the portfolio is: 98.1%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.54% -1.17%
ORGO Organogenesis Holdings Inc. Buy 6.74% -1.95%
CUTR Cutera, Inc. Sell -3.69% 2.67%
FATE Fate Therapeutics, Inc. Sell -3.47% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -3.81% -0.42%
IRTC iRhythm Technologies, Inc. Sell -3.41% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -3.58% 4.05%
The percentage of cash held in the portfolio is: 104.67%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.69% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.88% 0%
ORGO Organogenesis Holdings Inc. Buy 6.88% 0%
CUTR Cutera, Inc. Sell -3.79% 0%
FATE Fate Therapeutics, Inc. Sell -3.81% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -3.73% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.73% 0%
AXSM Axsome Therapeutics, Inc. Sell -3.73% 0%
The percentage of cash held in the portfolio is: 98.34%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
Asset Action Perf %
CERS Buy All 19.43%
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.64% 0%
CERS Cerus Corporation Sell -3.42% 19.91%
CUTR Cutera, Inc. Sell -3.8% 0%
FATE Fate Therapeutics, Inc. Sell -3.8% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -3.8% 0%
The percentage of cash held in the portfolio is: 108.17%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Sell -3.54% 17.06%
The percentage of cash held in the portfolio is: 103.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
LMAT Buy All -3%
AVXL Buy All 3.4%
PODD Sell All 13.51%
Assets Rebalanced
None
2024-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 10.49% 15.17%
LMAT LeMaitre Vascular, Inc. Sell -4.03% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.84% 3.57%
CERS Cerus Corporation Sell -3.6% 15.64%
The percentage of cash held in the portfolio is: 100.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All -4.63%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 10.56% 16.82%
STAA STAAR Surgical Company Sell -3.86% 4.11%
LMAT LeMaitre Vascular, Inc. Sell -3.96% -0.25%
AVXL Anavex Life Sciences Corp. Sell -3.66% 7.31%
CERS Cerus Corporation Sell -3.55% 16.11%
The percentage of cash held in the portfolio is: 104.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 8.57%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.86% 8%
PODD Insulet Corporation Buy 10.59% 16.92%
NVCR NovoCure Limited Buy 7.21% -8.98%
STAA STAAR Surgical Company Sell -4.02% 0.25%
LMAT LeMaitre Vascular, Inc. Sell -4.05% -2.35%
AVXL Anavex Life Sciences Corp. Sell -3.74% 5.44%
CERS Cerus Corporation Sell -3.62% 14.69%
The percentage of cash held in the portfolio is: 90.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.9% 9.14%
PODD Insulet Corporation Buy 10.54% 16.9%
NVCR NovoCure Limited Buy 7.21% -8.42%
MYGN Myriad Genetics, Inc. Buy 7.47% -0.15%
STAA STAAR Surgical Company Sell -3.76% 6.21%
LMAT LeMaitre Vascular, Inc. Sell -4.04% -2.66%
AVXL Anavex Life Sciences Corp. Sell -3.67% 6.63%
CERS Cerus Corporation Sell -3.56% 15.64%
The percentage of cash held in the portfolio is: 82.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.92% 10.29%
PODD Insulet Corporation Buy 10.35% 15.73%
ESPR Esperion Therapeutics, Inc. Buy 8.11% -8.2%
NVCR NovoCure Limited Buy 7.56% -3.32%
MYGN Myriad Genetics, Inc. Buy 7.61% 2.48%
STAA STAAR Surgical Company Sell -3.74% 6.12%
LMAT LeMaitre Vascular, Inc. Sell -3.95% -1.03%
AVXL Anavex Life Sciences Corp. Sell -3.75% 4.08%
CERS Cerus Corporation Sell -3.57% 14.69%
The percentage of cash held in the portfolio is: 74.44%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 6.76%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 6.59% 11.15%
AADI Aadi Bioscience, Inc. Buy 6.74% 7.43%
PODD Insulet Corporation Buy 10.24% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.5% -3.83%
NVCR NovoCure Limited Buy 7.78% -0.5%
MYGN Myriad Genetics, Inc. Buy 7.69% 3.45%
STAA STAAR Surgical Company Sell -3.86% 3.06%
LMAT LeMaitre Vascular, Inc. Sell -3.95% -1.08%
AVXL Anavex Life Sciences Corp. Sell -3.79% 3.06%
CERS Cerus Corporation Sell -4.09% 2.37%
The percentage of cash held in the portfolio is: 68.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -2.28%
APLS Sell All -8.89%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.8% -3.75%
AGEN Agenus Inc. Buy 6.22% 3.11%
AADI Aadi Bioscience, Inc. Buy 6.72% 5.14%
PODD Insulet Corporation Buy 10.15% 11.4%
MGNX MacroGenics, Inc. Buy 9.28% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 8.55% -4.92%
TVTX Travere Therapeutics, Inc. Buy 8.84% 27.5%
NVCR NovoCure Limited Buy 7.6% -4.54%
MYGN Myriad Genetics, Inc. Buy 7.37% -2.56%
STAA STAAR Surgical Company Sell -3.79% 6.36%
LMAT LeMaitre Vascular, Inc. Sell -3.87% 2.57%
AVXL Anavex Life Sciences Corp. Sell -3.47% 12.76%
CERS Cerus Corporation Sell -4.14% 2.84%
The percentage of cash held in the portfolio is: 44.75%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.22%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.92% -1.69%
AGEN Agenus Inc. Buy 6.01% -0.18%
AADI Aadi Bioscience, Inc. Buy 6.49% 1.71%
PODD Insulet Corporation Buy 10.08% 10.8%
MGNX MacroGenics, Inc. Buy 9.11% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 8.49% -5.46%
TVTX Travere Therapeutics, Inc. Buy 9.27% 33.75%
NVCR NovoCure Limited Buy 7.45% -6.37%
MYGN Myriad Genetics, Inc. Buy 7.57% 0.26%
STAA STAAR Surgical Company Sell -3.77% 6.89%
LMAT LeMaitre Vascular, Inc. Sell -3.85% 3.03%
AVXL Anavex Life Sciences Corp. Sell -3.38% 14.88%
VREX Varex Imaging Corporation Sell -4.13% 2.99%
CERS Cerus Corporation Sell -4.14% 2.84%
The percentage of cash held in the portfolio is: 48.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All 0.85%
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.01% 0.21%
CARA Cara Therapeutics, Inc. Buy 5.42% -9.62%
AGEN Agenus Inc. Buy 5.62% -6.22%
AADI Aadi Bioscience, Inc. Buy 6.57% 3.43%
PODD Insulet Corporation Buy 9.71% 7.2%
MGNX MacroGenics, Inc. Buy 8.79% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 8.31% -7.1%
TVTX Travere Therapeutics, Inc. Buy 9.24% 33.96%
NVCR NovoCure Limited Buy 7.28% -7.98%
MYGN Myriad Genetics, Inc. Buy 7.57% 0.63%
CDMO Avid Bioservices, Inc. Sell -3.36% 15.41%
STAA STAAR Surgical Company Sell -3.74% 7.17%
LMAT LeMaitre Vascular, Inc. Sell -3.84% 2.83%
AVXL Anavex Life Sciences Corp. Sell -3.46% 12.41%
VREX Varex Imaging Corporation Sell -3.71% 12.56%
CERS Cerus Corporation Sell -4.06% 4.27%
The percentage of cash held in the portfolio is: 47.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All -0.8%
PACB Buy All -22.96%
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.3% 3%
CARA Cara Therapeutics, Inc. Buy 5.75% -6.12%
AGEN Agenus Inc. Buy 5.54% -9.51%
AADI Aadi Bioscience, Inc. Buy 6.78% 4.57%
PODD Insulet Corporation Buy 9.71% 5.05%
MGNX MacroGenics, Inc. Buy 8.46% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 8.23% -9.84%
TVTX Travere Therapeutics, Inc. Buy 8.05% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 7.86% -3.01%
NVCR NovoCure Limited Buy 7.56% -6.48%
MYGN Myriad Genetics, Inc. Buy 7.68% 0%
CDMO Avid Bioservices, Inc. Sell -3.39% 16.54%
STAA STAAR Surgical Company Sell -3.95% 3.86%
LMAT LeMaitre Vascular, Inc. Sell -3.99% 1.1%
AVXL Anavex Life Sciences Corp. Sell -3.54% 12.41%
PACB Pacific Biosciences of California, Inc. Sell -4.73% -17.04%
BGNE BeiGene, Ltd. Sell -2.25% 0.24%
VREX Varex Imaging Corporation Sell -4.27% 1.28%
CERS Cerus Corporation Sell -4.14% 4.27%
The percentage of cash held in the portfolio is: 48.34%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.99% -1.42%
ORGO Organogenesis Holdings Inc. Buy 5.67% -6.71%
CARA Cara Therapeutics, Inc. Buy 5.69% -6.41%
AGEN Agenus Inc. Buy 5.56% -8.59%
AADI Aadi Bioscience, Inc. Buy 6.63% 2.86%
PODD Insulet Corporation Buy 9.71% 5.72%
MGNX MacroGenics, Inc. Buy 8.74% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 8.53% -6.01%
TVTX Travere Therapeutics, Inc. Buy 7.23% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 8.05% 0%
NVCR NovoCure Limited Buy 8.03% 0%
CDMO Avid Bioservices, Inc. Sell -3.43% 14.93%
STAA STAAR Surgical Company Sell -3.94% 3.61%
LMAT LeMaitre Vascular, Inc. Sell -3.97% 1.07%
AVXL Anavex Life Sciences Corp. Sell -3.79% 5.44%
PACB Pacific Biosciences of California, Inc. Sell -4.16% -3.7%
BGNE BeiGene, Ltd. Sell -2.24% 0.1%
VREX Varex Imaging Corporation Sell -4.4% -2.31%
CERS Cerus Corporation Sell -4.24% 1.42%
The percentage of cash held in the portfolio is: 50.33%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% -5.21%
ORGO Organogenesis Holdings Inc. Buy 5.79% -4.59%
CARA Cara Therapeutics, Inc. Buy 5.7% -6.12%
AGEN Agenus Inc. Buy 5.38% -11.33%
AADI Aadi Bioscience, Inc. Buy 6.62% 2.86%
PODD Insulet Corporation Buy 9.54% 3.96%
MGNX MacroGenics, Inc. Buy 8.57% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.01% -0.55%
TVTX Travere Therapeutics, Inc. Buy 7.31% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 8.04% 0%
CDMO Avid Bioservices, Inc. Sell -3.52% 12.67%
STAA STAAR Surgical Company Sell -3.97% 2.72%
LMAT LeMaitre Vascular, Inc. Sell -3.98% 0.61%
AVXL Anavex Life Sciences Corp. Sell -3.83% 4.42%
PACB Pacific Biosciences of California, Inc. Sell -3.92% 2.22%
BGNE BeiGene, Ltd. Sell -2.2% 1.63%
VREX Varex Imaging Corporation Sell -4.29% 0%
CERS Cerus Corporation Sell -4.29% 0%
The percentage of cash held in the portfolio is: 58.28%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.93% -2.65%
ORGO Organogenesis Holdings Inc. Buy 5.87% -3.53%
CARA Cara Therapeutics, Inc. Buy 5.88% -3.5%
AGEN Agenus Inc. Buy 5.51% -9.51%
CERS Cerus Corporation Buy 5.94% -7.98%
AADI Aadi Bioscience, Inc. Buy 6.41% -0.57%
PODD Insulet Corporation Buy 9.3% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.24% -10.38%
MGNX MacroGenics, Inc. Buy 8.49% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.08% 0%
TVTX Travere Therapeutics, Inc. Buy 7% 0%
CDMO Avid Bioservices, Inc. Sell -3.71% 8.03%
STAA STAAR Surgical Company Sell -4.08% 0.15%
LMAT LeMaitre Vascular, Inc. Sell -3.95% 1.75%
AVXL Anavex Life Sciences Corp. Sell -3.73% 7.14%
PACB Pacific Biosciences of California, Inc. Sell -3.99% 0.74%
BGNE BeiGene, Ltd. Sell -2.2% 1.84%
The percentage of cash held in the portfolio is: 44.01%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.72% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 5.75% -2.4%
ORGO Organogenesis Holdings Inc. Buy 6% 1.77%
CARA Cara Therapeutics, Inc. Buy 6.19% 4.96%
AGEN Agenus Inc. Buy 5.55% -5.85%
CERS Cerus Corporation Buy 5.93% -5.04%
AADI Aadi Bioscience, Inc. Buy 6.46% 3.43%
NEOG Neogen Corporation Buy 7.2% 0.35%
PODD Insulet Corporation Buy 8.83% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.8% -1.15%
MGNX MacroGenics, Inc. Buy 8.79% 0%
ESPR Esperion Therapeutics, Inc. Buy 8.79% 0%
CDMO Avid Bioservices, Inc. Sell -3.89% 0.38%
STAA STAAR Surgical Company Sell -4.05% -2.22%
PINC Premier, Inc. Sell -4.08% -2.93%
LMAT LeMaitre Vascular, Inc. Sell -3.94% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.98% -2.38%
VERU Veru Inc. Sell -3.94% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.95% -1.48%
BGNE BeiGene, Ltd. Sell -2.17% 0%
The percentage of cash held in the portfolio is: 45.97%
New Assets Added
  • BGNE
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.67% -3.77%
APLS Apellis Pharmaceuticals, Inc. Buy 5.72% -2.85%
ORGO Organogenesis Holdings Inc. Buy 6.03% 2.47%
CARA Cara Therapeutics, Inc. Buy 6.04% 2.62%
AGEN Agenus Inc. Buy 5.37% -8.78%
CERS Cerus Corporation Buy 6% -3.78%
AADI Aadi Bioscience, Inc. Buy 6.24% 0%
NEOG Neogen Corporation Buy 7.14% -0.41%
PODD Insulet Corporation Buy 8.93% 0.36%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.97% 0.77%
CDMO Avid Bioservices, Inc. Sell -3.82% 2.08%
STAA STAAR Surgical Company Sell -3.93% 0.71%
PINC Premier, Inc. Sell -4.04% -2.07%
LMAT LeMaitre Vascular, Inc. Sell -3.87% 0.47%
AVXL Anavex Life Sciences Corp. Sell -3.94% -1.53%
VERU Veru Inc. Sell -3.93% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.91% -0.74%
The percentage of cash held in the portfolio is: 61.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All 19.28%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.69% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 5.64% -4.2%
ORGO Organogenesis Holdings Inc. Buy 6.1% 3.53%
CARA Cara Therapeutics, Inc. Buy 6.11% 3.79%
AGEN Agenus Inc. Buy 5.5% -6.58%
CERS Cerus Corporation Buy 5.87% -5.88%
AADI Aadi Bioscience, Inc. Buy 5.99% -4%
NEOG Neogen Corporation Buy 7.01% -2.15%
PODD Insulet Corporation Buy 8.9% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.9% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.82% 22.87%
CDMO Avid Bioservices, Inc. Sell -3.77% 3.4%
STAA STAAR Surgical Company Sell -3.9% 1.42%
PINC Premier, Inc. Sell -3.97% -0.3%
LMAT LeMaitre Vascular, Inc. Sell -3.88% 0%
AVXL Anavex Life Sciences Corp. Sell -3.88% 0%
VERU Veru Inc. Sell -3.88% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.88% 0%
The percentage of cash held in the portfolio is: 64.28%
New Assets Added
  • LMAT
  • AVXL
  • VERU
  • PACB
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.68% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 5.78% -0.64%
ORGO Organogenesis Holdings Inc. Buy 6.05% 3.89%
CARA Cara Therapeutics, Inc. Buy 6.09% 4.66%
AGEN Agenus Inc. Buy 5.99% 2.93%
CERS Cerus Corporation Buy 6.01% -2.52%
AADI Aadi Bioscience, Inc. Buy 5.92% -4%
NEOG Neogen Corporation Buy 7.08% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.78% 22.87%
CDMO Avid Bioservices, Inc. Sell -3.75% 2.74%
STAA STAAR Surgical Company Sell -3.91% 0%
PINC Premier, Inc. Sell -3.91% 0%
The percentage of cash held in the portfolio is: 65.75%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
Asset Action Perf %
CYH Sell All 4.72%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.5% 6.09%
ARDX Ardelyx, Inc. Buy 5.7% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 5.75% -0.05%
ORGO Organogenesis Holdings Inc. Buy 6.16% 7.07%
CARA Cara Therapeutics, Inc. Buy 6.21% 7.87%
AGEN Agenus Inc. Buy 6.18% 7.31%
CERS Cerus Corporation Buy 6.1% 0%
AADI Aadi Bioscience, Inc. Buy 6.1% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.83% 20.63%
CDMO Avid Bioservices, Inc. Sell -3.74% 2.08%
The percentage of cash held in the portfolio is: 56.87%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.12% -0.59%
ARDX Ardelyx, Inc. Buy 5.81% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 5.86% 0.64%
ORGO Organogenesis Holdings Inc. Buy 6.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.91% 1.46%
AGEN Agenus Inc. Buy 6.18% 6.03%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.97% 17.94%
CDMO Avid Bioservices, Inc. Sell -3.86% 0%
The percentage of cash held in the portfolio is: 69.92%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.96% -4.32%
ARDX Ardelyx, Inc. Buy 5.62% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 5.81% -1.79%
ORGO Organogenesis Holdings Inc. Buy 5.75% -2.83%
CARA Cara Therapeutics, Inc. Buy 5.91% 0%
AGEN Agenus Inc. Buy 5.91% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.01% 17.94%
The percentage of cash held in the portfolio is: 67.06%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.02% -2.95%
ARDX Ardelyx, Inc. Buy 5.88% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 5.88% 0%
ORGO Organogenesis Holdings Inc. Buy 5.88% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.12% 14.35%
The percentage of cash held in the portfolio is: 78.46%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.08% -1.57%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.7% 25.56%
The percentage of cash held in the portfolio is: 95.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 4.43%
NKTR Buy All 7.41%
RCM Sell All 7.37%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.55% 7.37%
CYH Community Health Systems, Inc. Buy 6.8% -4.91%
NKTR Nektar Therapeutics Sell -3.02% 17.78%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.59% 28.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.11% 13.71%
The percentage of cash held in the portfolio is: 95.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 13.64%
AVNS Sell All 6.33%
SGRY Sell All 16.4%
RGNX Sell All -8.1%
ANGO Sell All 21.37%
Assets Rebalanced
None
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.7% 8.33%
AVNS Avanos Medical, Inc. Buy 6.52% 8.69%
SGRY Surgery Partners, Inc. Buy 7.04% 17.34%
RGNX REGENXBIO Inc. Buy 5.05% -6.45%
ANGO AngioDynamics, Inc. Buy 7.56% 23.82%
RCM R1 RCM Inc. Buy 6.55% 7.21%
CYH Community Health Systems, Inc. Buy 6.95% -2.95%
NKTR Nektar Therapeutics Sell -3.3% 10.37%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.72% 24.66%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.16% 12.45%
The percentage of cash held in the portfolio is: 63.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
CPRX Buy All -6.15%
PODD Buy All -2.48%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.15% -3.03%
AVNS Avanos Medical, Inc. Buy 6.42% 6.19%
SGRY Surgery Partners, Inc. Buy 6.77% 11.98%
RGNX REGENXBIO Inc. Buy 5.16% -5.27%
ANGO AngioDynamics, Inc. Buy 7.26% 17.78%
RCM R1 RCM Inc. Buy 6.6% 7.14%
CYH Community Health Systems, Inc. Buy 6.67% -7.66%
PODD Insulet Corporation Sell -3.63% 2.34%
NKTR Nektar Therapeutics Sell -3.25% 12.59%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.55% 30.04%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.27% 10.34%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.83% 5.86%
The percentage of cash held in the portfolio is: 72.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Buy All -20.7%
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.14% -0.76%
AVNS Avanos Medical, Inc. Buy 6.39% 8.36%
SGRY Surgery Partners, Inc. Buy 6.63% 12.41%
RGNX REGENXBIO Inc. Buy 5.23% -1.57%
ANGO AngioDynamics, Inc. Buy 7.33% 22.02%
RCM R1 RCM Inc. Buy 6.43% 7.06%
CYH Community Health Systems, Inc. Buy 6.67% -5.3%
RMD ResMed Inc. Buy 13.94% 3.67%
PODD Insulet Corporation Sell -3.54% 2.25%
NKTR Nektar Therapeutics Sell -3.14% 13.33%
INGN Inogen, Inc. Sell -3.17% 10.89%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.42% 31.84%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.27% 8.02%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.56% 10.15%
The percentage of cash held in the portfolio is: 61.35%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -10.51%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.25% 2.27%
PDSB PDS Biotechnology Corporation Buy 4.12% -8.52%
AVNS Avanos Medical, Inc. Buy 6.63% 13.36%
SGRY Surgery Partners, Inc. Buy 6.65% 13.78%
RGNX REGENXBIO Inc. Buy 5.4% 2.6%
ANGO AngioDynamics, Inc. Buy 7.55% 26.75%
RCM R1 RCM Inc. Buy 6.42% 7.83%
CYH Community Health Systems, Inc. Buy 6.85% -1.96%
RMD ResMed Inc. Buy 14.32% 7.5%
PODD Insulet Corporation Sell -3.62% -0.76%
NKTR Nektar Therapeutics Sell -3.19% 11.11%
INGN Inogen, Inc. Sell -3.28% 6.97%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.69% 23.77%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.42% 2.95%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.75% 4.47%
The percentage of cash held in the portfolio is: 56.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
RARE Buy All -17.98%
CUTR Sell All -19.59%
HQY Sell All -11.82%
SAVA Sell All 95.11%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.49% 4.55%
PDSB PDS Biotechnology Corporation Buy 4.23% -8.24%
AVNS Avanos Medical, Inc. Buy 6.71% 12.13%
SGRY Surgery Partners, Inc. Buy 7.08% 18.28%
RGNX REGENXBIO Inc. Buy 5.64% 4.72%
ANGO AngioDynamics, Inc. Buy 7.75% 27.08%
CUTR Cutera, Inc. Buy 4.59% -12.16%
RCM R1 RCM Inc. Buy 6.61% 8.44%
CYH Community Health Systems, Inc. Buy 7.04% -1.57%
HQY HealthEquity, Inc. Buy 6.87% -3.84%
SAVA Cassava Sciences, Inc. Buy 11.26% 57.44%
HCSG Healthcare Services Group, Inc. Buy 2.46% -3.72%
RMD ResMed Inc. Buy 14.06% 3.13%
PODD Insulet Corporation Sell -3.72% -1.17%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.79% -3.2%
NKTR Nektar Therapeutics Sell -3.46% 5.93%
INGN Inogen, Inc. Sell -3.58% 0.87%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.27% 9.42%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.64% -0.84%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.95% 1.8%
The percentage of cash held in the portfolio is: 35.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.62% 7.58%
PDSB PDS Biotechnology Corporation Buy 4.64% 1.14%
AVNS Avanos Medical, Inc. Buy 6.72% 12.94%
SGRY Surgery Partners, Inc. Buy 7.07% 18.83%
RGNX REGENXBIO Inc. Buy 6.01% 12.12%
ANGO AngioDynamics, Inc. Buy 7.75% 27.9%
CUTR Cutera, Inc. Buy 4.92% -5.41%
RCM R1 RCM Inc. Buy 5.99% -1.15%
FATE Fate Therapeutics, Inc. Buy 7.67% -4.31%
CYH Community Health Systems, Inc. Buy 7.35% 3.34%
HQY HealthEquity, Inc. Buy 6.89% -3.09%
SAVA Cassava Sciences, Inc. Buy 10.59% 48.93%
HCSG Healthcare Services Group, Inc. Buy 2.51% -1.12%
RMD ResMed Inc. Buy 13.9% 2.5%
PODD Insulet Corporation Sell -3.64% 0.31%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.85% -5.24%
NKTR Nektar Therapeutics Sell -3.63% 0.74%
INGN Inogen, Inc. Sell -3.61% -0.76%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.62% -0.9%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.65% -1.69%
CPRX Catalyst Pharmaceuticals, Inc. Sell -4% 0%
The percentage of cash held in the portfolio is: 28.38%
New Assets Added
  • CPRX
Assets Removed
Asset Action Perf %
SMTI Buy All -6.87%
VRDN Sell All 27.55%
RYTM Sell All 12.98%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 7% 26.42%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.94% 11.69%
OPK OPKO Health, Inc. Buy 5.82% 8.33%
PDSB PDS Biotechnology Corporation Buy 4.64% -1.7%
AVNS Avanos Medical, Inc. Buy 6.64% 8.4%
SGRY Surgery Partners, Inc. Buy 7.49% 22.27%
RGNX REGENXBIO Inc. Buy 6.2% 12.43%
ANGO AngioDynamics, Inc. Buy 7.97% 27.73%
CUTR Cutera, Inc. Buy 5.2% -2.7%
RCM R1 RCM Inc. Buy 6.18% -1%
FATE Fate Therapeutics, Inc. Buy 7.6% -7.9%
CYH Community Health Systems, Inc. Buy 7.42% 1.38%
HQY HealthEquity, Inc. Buy 7.08% -3.16%
SAVA Cassava Sciences, Inc. Buy 8.61% 17.76%
HCSG Healthcare Services Group, Inc. Buy 2.6% -0.43%
RMD ResMed Inc. Buy 13.95% 0%
PODD Insulet Corporation Sell -3.74% 0.6%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.93% -4.51%
NKTR Nektar Therapeutics Sell -3.87% -2.96%
SMTI Sanara MedTech Inc. Sell -3.69% 0%
INGN Inogen, Inc. Sell -3.69% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.69% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.69% 0%
The percentage of cash held in the portfolio is: 15.95%
New Assets Added
  • SMTI
  • INGN
  • LXRX
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 7.1% 30.89%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.95% 14.23%
OPK OPKO Health, Inc. Buy 5.7% 8.33%
PDSB PDS Biotechnology Corporation Buy 5.02% 8.52%
AVNS Avanos Medical, Inc. Buy 6.48% 8.03%
SGRY Surgery Partners, Inc. Buy 7.3% 21.76%
RGNX REGENXBIO Inc. Buy 6.1% 12.9%
ANGO AngioDynamics, Inc. Buy 7.63% 24.96%
CUTR Cutera, Inc. Buy 4.95% -5.41%
RCM R1 RCM Inc. Buy 5.95% -2.61%
FATE Fate Therapeutics, Inc. Buy 7.85% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 6.87% -4.26%
SMTI Sanara MedTech Inc. Buy 6.77% -5.45%
CYH Community Health Systems, Inc. Buy 7.29% 1.77%
HQY HealthEquity, Inc. Buy 7.04% -1.69%
SAVA Cassava Sciences, Inc. Buy 8.65% 20.78%
HCSG Healthcare Services Group, Inc. Buy 2.56% 0%
PODD Insulet Corporation Sell -3.63% 1.61%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.9% -5.75%
NKTR Nektar Therapeutics Sell -3.71% -0.74%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 6.8% 26.12%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.95% 14.95%
OPK OPKO Health, Inc. Buy 5.86% 12.12%
PDSB PDS Biotechnology Corporation Buy 5.06% 10.23%
AVNS Avanos Medical, Inc. Buy 6.51% 9.25%
SGRY Surgery Partners, Inc. Buy 7.46% 25.32%
RGNX REGENXBIO Inc. Buy 6.05% 12.75%
ANGO AngioDynamics, Inc. Buy 7.57% 24.8%
CUTR Cutera, Inc. Buy 5.34% 2.7%
RCM R1 RCM Inc. Buy 6.06% -0.19%
FATE Fate Therapeutics, Inc. Buy 7.84% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 6.75% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 7.24% 1.6%
SMTI Sanara MedTech Inc. Buy 7.12% 0%
CYH Community Health Systems, Inc. Buy 7.12% 0%
HQY HealthEquity, Inc. Buy 7.12% 0%
SAVA Cassava Sciences, Inc. Buy 7.12% 0%
PODD Insulet Corporation Sell -3.63% 0.85%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.84% -4.86%
NKTR Nektar Therapeutics Sell -3.74% -2.22%
RMD ResMed Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
  • SAVA
Assets Removed
Asset Action Perf %
WAT Buy All -5.03%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 6.73% 23.69%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.08% 16.26%
OPK OPKO Health, Inc. Buy 5.68% 7.58%
PDSB PDS Biotechnology Corporation Buy 5.19% 11.93%
AVNS Avanos Medical, Inc. Buy 6.51% 8.22%
SGRY Surgery Partners, Inc. Buy 7.24% 20.35%
RGNX REGENXBIO Inc. Buy 6.13% 13.22%
ANGO AngioDynamics, Inc. Buy 7.51% 22.51%
CUTR Cutera, Inc. Buy 4.97% -5.41%
RCM R1 RCM Inc. Buy 6.08% -0.84%
FATE Fate Therapeutics, Inc. Buy 7.86% -3.05%
PTGX Protagonist Therapeutics, Inc. Buy 7.04% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 7.2% 0%
PODD Insulet Corporation Sell -3.62% 2.09%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.89% -5.33%
NKTR Nektar Therapeutics Sell -3.75% -1.48%
WAT Waters Corporation Sell -3.74% -2.5%
The percentage of cash held in the portfolio is: 30.8%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
CYH Sell All 48.75%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.14% 35.31%
VRDN Viridian Therapeutics, Inc. Buy 6.66% 19.76%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.18% 15.58%
OPK OPKO Health, Inc. Buy 5.8% 7.58%
PDSB PDS Biotechnology Corporation Buy 5.07% 6.96%
AVNS Avanos Medical, Inc. Buy 6.56% 6.7%
SGRY Surgery Partners, Inc. Buy 7.14% 16.16%
RGNX REGENXBIO Inc. Buy 5.94% 7.32%
ANGO AngioDynamics, Inc. Buy 7.49% 19.58%
CUTR Cutera, Inc. Buy 5.22% -2.7%
RCM R1 RCM Inc. Buy 6.32% 0.92%
FATE Fate Therapeutics, Inc. Buy 7.71% -7%
PTGX Protagonist Therapeutics, Inc. Buy 7.25% 0%
PODD Insulet Corporation Sell -3.77% 0.3%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.98% -5.45%
NKTR Nektar Therapeutics Sell -3.94% -4.44%
WAT Waters Corporation Sell -3.76% -0.86%
The percentage of cash held in the portfolio is: 30.99%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
EGRX Sell All 20.09%
ACAD Sell All 16.37%
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 5.92% 28.79%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.59% 14.55%
CYH Community Health Systems, Inc. Buy 6.59% 26.56%
VRDN Viridian Therapeutics, Inc. Buy 6.48% 18.17%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.15% 16.71%
OPK OPKO Health, Inc. Buy 5.81% 9.09%
PDSB PDS Biotechnology Corporation Buy 5.62% 20.17%
AVNS Avanos Medical, Inc. Buy 6.5% 7.18%
SGRY Surgery Partners, Inc. Buy 6.73% 10.92%
RGNX REGENXBIO Inc. Buy 5.8% 6.22%
ANGO AngioDynamics, Inc. Buy 7.54% 22.02%
CUTR Cutera, Inc. Buy 5.65% 6.76%
RCM R1 RCM Inc. Buy 6.37% 3.07%
FATE Fate Therapeutics, Inc. Buy 8.17% 0%
PODD Insulet Corporation Sell -3.76% -0.92%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.94% -5.61%
NKTR Nektar Therapeutics Sell -4.08% -9.63%
WAT Waters Corporation Sell -3.66% 0.62%
The percentage of cash held in the portfolio is: 26.52%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 6.02% 29.24%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.65% 14.17%
CYH Community Health Systems, Inc. Buy 6.51% 23.44%
VRDN Viridian Therapeutics, Inc. Buy 6.3% 13.4%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.23% 16.66%
OPK OPKO Health, Inc. Buy 5.97% 10.61%
PDSB PDS Biotechnology Corporation Buy 5.25% 10.8%
AVNS Avanos Medical, Inc. Buy 6.53% 6.28%
SGRY Surgery Partners, Inc. Buy 6.78% 10.29%
RGNX REGENXBIO Inc. Buy 5.56% 0.47%
ANGO AngioDynamics, Inc. Buy 7.28% 16.31%
CUTR Cutera, Inc. Buy 5.91% 10.14%
RCM R1 RCM Inc. Buy 6.4% 2.15%
PODD Insulet Corporation Sell -3.76% 0.37%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.92% -3.93%
NKTR Nektar Therapeutics Sell -4.08% -8.15%
WAT Waters Corporation Sell -3.79% -1.49%
The percentage of cash held in the portfolio is: 35.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Buy All -22.33%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 6.07% 31.03%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.5% 11.78%
CYH Community Health Systems, Inc. Buy 6.18% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 6.06% 9.54%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.17% 16.17%
OPK OPKO Health, Inc. Buy 6.06% 12.88%
PDSB PDS Biotechnology Corporation Buy 5.18% 9.94%
AVNS Avanos Medical, Inc. Buy 6.35% 3.82%
SGRY Surgery Partners, Inc. Buy 6.95% 13.7%
RGNX REGENXBIO Inc. Buy 5.45% -1.02%
ANGO AngioDynamics, Inc. Buy 7.29% 17.13%
CUTR Cutera, Inc. Buy 5.73% 7.43%
RCM R1 RCM Inc. Buy 6.35% 2%
FGEN FibroGen, Inc. Sell -3.8% -1.94%
PODD Insulet Corporation Sell -3.76% -0.04%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.74% 0.54%
NKTR Nektar Therapeutics Sell -3.87% -2.96%
WAT Waters Corporation Sell -3.71% 0%
The percentage of cash held in the portfolio is: 39.53%
New Assets Added
  • WAT
Assets Removed
Asset Action Perf %
TDOC Sell All -2.99%
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 5.95% 28.57%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.56% 13.35%
CYH Community Health Systems, Inc. Buy 6.17% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 6.05% 9.54%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.12% 15.44%
OPK OPKO Health, Inc. Buy 6.17% 15.15%
ALT Altimmune, Inc. Buy 5.15% -12.43%
PDSB PDS Biotechnology Corporation Buy 5.16% 9.66%
AVNS Avanos Medical, Inc. Buy 6.46% 5.95%
TDOC Teladoc Health, Inc. Buy 6.06% -0.64%
SGRY Surgery Partners, Inc. Buy 6.95% 13.89%
RGNX REGENXBIO Inc. Buy 5.56% 1.1%
ANGO AngioDynamics, Inc. Buy 7.05% 13.38%
CUTR Cutera, Inc. Buy 5.58% 4.73%
RCM R1 RCM Inc. Buy 6.13% -1.46%
FGEN FibroGen, Inc. Sell -3.76% -0.97%
PODD Insulet Corporation Sell -3.75% 0%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.75% 0%
NKTR Nektar Therapeutics Sell -3.75% 0%
The percentage of cash held in the portfolio is: 24.9%
New Assets Added
  • PODD
  • RARE
  • NKTR
Assets Removed
Asset Action Perf %
RARE Sell All 7.35%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 5.95% 33.48%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.46% 15.55%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.71% 10.14%
CYH Community Health Systems, Inc. Buy 6.21% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 6.13% 15.37%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.23% 22.05%
OPK OPKO Health, Inc. Buy 5.55% 7.58%
ALT Altimmune, Inc. Buy 5.68% 0.13%
PDSB PDS Biotechnology Corporation Buy 5.16% 13.92%
WST West Pharmaceutical Services, Inc. Buy 5.76% -1.88%
AVNS Avanos Medical, Inc. Buy 6.28% 6.89%
TDOC Teladoc Health, Inc. Buy 6.29% 7.04%
SGRY Surgery Partners, Inc. Buy 6.79% 15.66%
RGNX REGENXBIO Inc. Buy 5.53% 4.48%
ANGO AngioDynamics, Inc. Buy 7.22% 20.72%
CUTR Cutera, Inc. Buy 5.79% 12.84%
RCM R1 RCM Inc. Buy 5.98% 0%
FGEN FibroGen, Inc. Sell -3.72% -3.88%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 6.14% 33.26%
ACAD ACADIA Pharmaceuticals Inc. Buy 5.55% 13.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.99% 11.57%
CYH Community Health Systems, Inc. Buy 6.36% 21.88%
VRDN Viridian Therapeutics, Inc. Buy 6.11% 11.2%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.43% 21.63%
OPK OPKO Health, Inc. Buy 5.78% 8.33%
ALT Altimmune, Inc. Buy 6.19% 5.61%
BHVN Biohaven Ltd. Buy 6.25% 6.27%
PDSB PDS Biotechnology Corporation Buy 5.62% 20.03%
WST West Pharmaceutical Services, Inc. Buy 5.84% -3.96%
AVNS Avanos Medical, Inc. Buy 6.01% -1.18%
TDOC Teladoc Health, Inc. Buy 6.01% -1.17%
SGRY Surgery Partners, Inc. Buy 6.12% 0.74%
RGNX REGENXBIO Inc. Buy 5.54% 1.26%
ANGO AngioDynamics, Inc. Buy 5.99% -3.26%
CUTR Cutera, Inc. Buy 5.52% 4.05%
FGEN FibroGen, Inc. Sell -3.82% -2.91%
The percentage of cash held in the portfolio is: 2.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Buy All -10.22%
Assets Rebalanced
Asset Action Weight
RGNX Sell -0.61%
CUTR Sell -0.8%
PDSB Sell -0.78%
ACAD Sell -0.95%
ANGO Sell -0.61%
RARE Sell -0.72%
2024-07-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.46% 11.9%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.24% 34.37%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.86% 13.27%
CYH Community Health Systems, Inc. Buy 6.24% 18.75%
VRDN Viridian Therapeutics, Inc. Buy 5.83% 5.15%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.24% 17.23%
BHVN Biohaven Ltd. Buy 6.24% 5.28%
ALT Altimmune, Inc. Buy 6.24% 5.61%
OPK OPKO Health, Inc. Buy 5.62% 4.55%
PDSB PDS Biotechnology Corporation Buy 6.24% 16.19%
SGRY Surgery Partners, Inc. Buy 6.44% 5.17%
RGNX REGENXBIO Inc. Buy 6.16% 0.47%
TDOC Teladoc Health, Inc. Buy 6.14% 0.21%
AVNS Avanos Medical, Inc. Buy 6.1% -0.47%
CUTR Cutera, Inc. Buy 6.09% -0.68%
ANGO AngioDynamics, Inc. Buy 6.74% -2.12%
WST West Pharmaceutical Services, Inc. Buy 5.94% -3.1%
FGEN FibroGen, Inc. Sell -3.78% -0.97%
APLS Apellis Pharmaceuticals, Inc. Sell -4.37% -8.93%
The percentage of cash held in the portfolio is: 2.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Buy All -25%
CDNA Buy All -10.41%
Assets Rebalanced
Asset Action Weight
VRDN Sell -0.97%
OPK Sell -1.34%
BHVN Sell -0.77%
ALT Sell -0.79%
RYTM Sell -1.33%
PDSB Sell -1.49%
EGRX Sell -1.51%
CYH Sell -1.55%
ANGO Buy 0.25%
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.52% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.89% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.78% 10.14%
CYH Community Health Systems, Inc. Buy 7.73% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 6.44% -1.97%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.17% 9.21%
PDSB PDS Biotechnology Corporation Buy 7.46% 10.23%
BHVN Biohaven Ltd. Buy 7.1% 4.89%
ALT Altimmune, Inc. Buy 6.95% 2.67%
OPK OPKO Health, Inc. Buy 7.02% 3.79%
WST West Pharmaceutical Services, Inc. Buy 6.23% 0%
ANGO AngioDynamics, Inc. Buy 6.23% 0%
TDOC Teladoc Health, Inc. Buy 6.23% 0%
SGRY Surgery Partners, Inc. Buy 6.23% 0%
AVNS Avanos Medical, Inc. Buy 6.23% 0%
CUTR Cutera, Inc. Buy 6.23% 0%
RGNX REGENXBIO Inc. Buy 6.23% 0%
FGEN FibroGen, Inc. Sell -3.61% 4.95%
SGMO Sangamo Therapeutics, Inc. Sell -4.83% -22.22%
APLS Apellis Pharmaceuticals, Inc. Sell -4.37% -7.16%
CDNA CareDx, Inc Sell -3.83% -9.44%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
  • ANGO
  • TDOC
  • SGRY
  • AVNS
  • CUTR
  • RGNX
Assets Removed
Asset Action Perf %
PAHC Buy All -6.77%
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.44% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.06% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.69% 6.55%
CYH Community Health Systems, Inc. Buy 7.09% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 6.21% -7.12%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.96% 4.01%
PDSB PDS Biotechnology Corporation Buy 6.9% 0%
BHVN Biohaven Ltd. Buy 6.9% 0%
ALT Altimmune, Inc. Buy 6.9% 0%
OPK OPKO Health, Inc. Buy 6.9% 0%
FGEN FibroGen, Inc. Sell -3.39% 12.33%
SGMO Sangamo Therapeutics, Inc. Sell -4.47% -11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.29% -3.17%
PAHC Phibro Animal Health Corporation Sell -3.57% 0%
CDNA CareDx, Inc Sell -3.57% 0%
The percentage of cash held in the portfolio is: 50.27%
New Assets Added
  • PAHC
  • CDNA
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.39% 7.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.03% 35.49%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.59% 6.02%
CYH Community Health Systems, Inc. Buy 6.99% 3.75%
VRDN Viridian Therapeutics, Inc. Buy 6.2% -6.59%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.99% 5.32%
FGEN FibroGen, Inc. Sell -3.13% 18.54%
SGMO Sangamo Therapeutics, Inc. Sell -3.88% 2.78%
APLS Apellis Pharmaceuticals, Inc. Sell -4.26% -3.44%
The percentage of cash held in the portfolio is: 70.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Sell All -11.61%
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.07% 2.77%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.93% 34.15%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.46% 4.12%
CYH Community Health Systems, Inc. Buy 6.8% 1.25%
NVRO Nevro Corp. Buy 6.43% -2.79%
VRDN Viridian Therapeutics, Inc. Buy 6.17% -6.81%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.79% 2.55%
FGEN FibroGen, Inc. Sell -3.01% 21.46%
SGMO Sangamo Therapeutics, Inc. Sell -3.54% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.19% -1.98%
The percentage of cash held in the portfolio is: 64.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
VERU Sell All -3.41%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.82% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.28% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.28% 0.9%
CYH Community Health Systems, Inc. Buy 7.09% 5.31%
NVRO Nevro Corp. Buy 6.46% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 6.15% -7.27%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.35% -4.36%
VERU Veru Inc. Buy 6.86% 3.41%
FGEN FibroGen, Inc. Sell -2.58% 32.91%
SGMO Sangamo Therapeutics, Inc. Sell -3.55% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.02% 2.42%
The percentage of cash held in the portfolio is: 57.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.88% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.88% 16.74%
STAA STAAR Surgical Company Buy 6.51% 5.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.36% 2.79%
CYH Community Health Systems, Inc. Buy 7.18% 7.19%
NVRO Nevro Corp. Buy 6.4% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 6.08% -7.95%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.55% -0.77%
VERU Veru Inc. Buy 7.13% 7.95%
FGEN FibroGen, Inc. Sell -2.76% 27.86%
SGMO Sangamo Therapeutics, Inc. Sell -3.53% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -3.96% 3.61%
The percentage of cash held in the portfolio is: 51.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.74% 1.01%
MNKD MannKind Corporation Buy 5.33% -6.26%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.02% 23.44%
STAA STAAR Surgical Company Buy 6.69% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.16% 3.19%
CYH Community Health Systems, Inc. Buy 6.7% 3.75%
ARDX Ardelyx, Inc. Buy 6.95% 2.16%
CHRS Coherus BioSciences, Inc. Buy 6.33% -6.94%
NVRO Nevro Corp. Buy 6.37% 0%
VRDN Viridian Therapeutics, Inc. Buy 6.37% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.37% 0%
VERU Veru Inc. Buy 6.37% 0%
FGEN FibroGen, Inc. Sell -2.75% 25.24%
SGMO Sangamo Therapeutics, Inc. Sell -3.51% 8.33%
APLS Apellis Pharmaceuticals, Inc. Sell -3.96% 0%
The percentage of cash held in the portfolio is: 33.83%
New Assets Added
  • APLS
  • NVRO
  • VRDN
  • RYTM
  • VERU
Assets Removed
Asset Action Perf %
NVRO Buy All -8.17%
MODV Buy All -8.11%
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.81% 2.33%
MNKD MannKind Corporation Buy 5.46% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.09% 25%
STAA STAAR Surgical Company Buy 6.7% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.15% 3.14%
CYH Community Health Systems, Inc. Buy 6.77% 5%
ARDX Ardelyx, Inc. Buy 6.79% 0%
CHRS Coherus BioSciences, Inc. Buy 6.79% 0%
NVRO Nevro Corp. Sell -3.89% -5.78%
MODV ModivCare Inc. Sell -3.82% -4.83%
FGEN FibroGen, Inc. Sell -3.18% 13.4%
SGMO Sangamo Therapeutics, Inc. Sell -3.82% 0%
The percentage of cash held in the portfolio is: 63.15%
New Assets Added
  • SGMO
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.93% 3.09%
MNKD MannKind Corporation Buy 5.6% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.44% 12.05%
STAA STAAR Surgical Company Buy 6.67% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.28% 3.94%
CYH Community Health Systems, Inc. Buy 6.54% 0%
NVRO Nevro Corp. Sell -3.92% -5.03%
MODV ModivCare Inc. Sell -3.73% -0.84%
FGEN FibroGen, Inc. Sell -3.73% 0%
The percentage of cash held in the portfolio is: 73.9%
New Assets Added
  • FGEN
  • CYH
Assets Removed
Asset Action Perf %
AVXL Buy All -12.3%
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.64% -2.39%
MNKD MannKind Corporation Buy 5.52% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.35% 9.82%
STAA STAAR Surgical Company Buy 6.52% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.17% 1.71%
NVRO Nevro Corp. Sell -4.01% -7.16%
MODV ModivCare Inc. Sell -3.71% 0%
AVXL Anavex Life Sciences Corp. Sell -3.71% 0%
The percentage of cash held in the portfolio is: 81.24%
New Assets Added
  • MODV
  • AVXL
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.68% -1.76%
MNKD MannKind Corporation Buy 5.58% -3.5%
FGEN FibroGen, Inc. Buy 5.64% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.88% 1.56%
STAA STAAR Surgical Company Buy 6.07% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.07% 0%
NVRO Nevro Corp. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 68.82%
New Assets Added
  • NVRO
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.76% 0%
MNKD MannKind Corporation Buy 5.76% 0%
FGEN FibroGen, Inc. Buy 5.76% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 76.94%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-06-17 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All 0.32%
Assets Rebalanced
None
2024-06-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -2.15% -1.44%
The percentage of cash held in the portfolio is: 102.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGRY Buy All 6.39%
Assets Rebalanced
None
2024-06-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -2.24% 2.64%
SGRY Surgery Partners, Inc. Sell -1.71% 4.25%
The percentage of cash held in the portfolio is: 103.95%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Buy All 12.51%
Assets Rebalanced
None
2024-06-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -2.24% 2.24%
VRDN Viridian Therapeutics, Inc. Sell -3.46% 12.08%
SGRY Surgery Partners, Inc. Sell -1.74% 2.48%
The percentage of cash held in the portfolio is: 107.43%
New Assets Added
None
Assets Removed
Asset Action Perf %
ILMN Buy All -1.68%
Assets Rebalanced
None
2024-06-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -2.22% 2.16%
ILMN Illumina, Inc. Sell -3.77% 9.54%
VRDN Viridian Therapeutics, Inc. Sell -3.26% 16.61%
SGRY Surgery Partners, Inc. Sell -1.72% 2.97%
The percentage of cash held in the portfolio is: 110.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
AORT Sell All 11.42%
OMCL Sell All 1.76%
Assets Rebalanced
None
2024-06-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 7.61% 12.42%
OMCL Omnicell, Inc. Buy 8.65% 4.91%
RCM R1 RCM Inc. Buy -2.22% 2.32%
ILMN Illumina, Inc. Sell -3.82% 8.38%
VRDN Viridian Therapeutics, Inc. Sell -3.36% 13.73%
SGRY Surgery Partners, Inc. Sell -1.76% 0.38%
The percentage of cash held in the portfolio is: 94.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Buy All -6.33%
Assets Rebalanced
None
2024-06-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 7.6% 12.76%
OMCL Omnicell, Inc. Buy 8.89% 8.16%
RCM R1 RCM Inc. Buy -2.22% 2.88%
ILMN Illumina, Inc. Sell -3.84% 7.57%
VRDN Viridian Therapeutics, Inc. Sell -3.34% 14.09%
SGRY Surgery Partners, Inc. Sell -1.83% -3.8%
ICUI ICU Medical, Inc. Sell -4.81% -2.26%
The percentage of cash held in the portfolio is: 99.55%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Sell All 17.73%
ALT Sell All 4.45%
KIDS Sell All -0.72%
GKOS Sell All 7.32%
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 8.75% 14.89%
ALT Altimmune, Inc. Buy 7.78% -4.73%
KIDS OrthoPediatrics Corp. Buy 8.21% 2.07%
GKOS Glaukos Corporation Buy 8.36% 5.06%
AORT Artivion, Inc. Buy 7.71% 13.47%
OMCL Omnicell, Inc. Buy 8.74% 5.58%
RCM R1 RCM Inc. Buy -2.24% 3.04%
ILMN Illumina, Inc. Sell -3.77% 9.8%
VRDN Viridian Therapeutics, Inc. Sell -3.37% 13.87%
SGRY Surgery Partners, Inc. Sell -1.78% -0.6%
ICUI ICU Medical, Inc. Sell -4.61% 2.74%
The percentage of cash held in the portfolio is: 66.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Buy All -12.87%
ALGN Buy All 17.08%
SGMO Sell All 5.56%
Assets Rebalanced
None
2024-05-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 9.14% 21.99%
SGMO Sangamo Therapeutics, Inc. Buy 10.09% 14.81%
ALT Altimmune, Inc. Buy 7.78% -3.06%
KIDS OrthoPediatrics Corp. Buy 8.41% 6.35%
GKOS Glaukos Corporation Buy 8.14% 4.07%
AORT Artivion, Inc. Buy 7.49% 12.04%
OMCL Omnicell, Inc. Buy 8.76% 7.53%
RCM R1 RCM Inc. Buy -2.18% 2%
ALGN Align Technology, Inc. Sell -3.19% 16.75%
ILMN Illumina, Inc. Sell -3.83% 6.9%
VRDN Viridian Therapeutics, Inc. Sell -3.37% 12.37%
SGRY Surgery Partners, Inc. Sell -1.68% 3.99%
ICUI ICU Medical, Inc. Sell -4.71% -0.88%
TVTX Travere Therapeutics, Inc. Sell -5.2% -11.55%
The percentage of cash held in the portfolio is: 64.35%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Buy All -16.51%
VKTX Buy All 5.36%
NUTX Sell All 3.27%
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 9.17% 24.96%
SGMO Sangamo Therapeutics, Inc. Buy 9.56% 11.11%
ALT Altimmune, Inc. Buy 8.02% 1.95%
KIDS OrthoPediatrics Corp. Buy 7.93% 2.29%
GKOS Glaukos Corporation Buy 7.94% 3.68%
NUTX Nutex Health Inc. Buy 9.59% 9.74%
AORT Artivion, Inc. Buy 7.43% 13.62%
OMCL Omnicell, Inc. Buy 8.64% 8.3%
RCM R1 RCM Inc. Buy -2.09% -0.16%
ALGN Align Technology, Inc. Sell -3.15% 16.14%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.05% -0.53%
ILMN Illumina, Inc. Sell -3.8% 5.62%
VRDN Viridian Therapeutics, Inc. Sell -3.28% 12.94%
SGRY Surgery Partners, Inc. Sell -1.63% 4.51%
VKTX Viking Therapeutics, Inc. Sell -3.98% 9.14%
ICUI ICU Medical, Inc. Sell -4.47% 2.22%
TVTX Travere Therapeutics, Inc. Sell -4.64% -1.65%
The percentage of cash held in the portfolio is: 62.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -11.24%
SENS Sell All -8.83%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 6.14% -2.91%
SENS Senseonics Holdings, Inc. Buy 6.47% -7.8%
INGN Inogen, Inc. Buy 8.62% 17.02%
SGMO Sangamo Therapeutics, Inc. Buy 9.92% 14.81%
ALT Altimmune, Inc. Buy 8.11% 2.78%
KIDS OrthoPediatrics Corp. Buy 7.76% -0.25%
GKOS Glaukos Corporation Buy 7.87% 2.29%
NUTX Nutex Health Inc. Buy 9.56% 8.86%
AORT Artivion, Inc. Buy 7.42% 13%
OMCL Omnicell, Inc. Buy 8.42% 5.21%
RCM R1 RCM Inc. Buy -2.04% -2.92%
ALGN Align Technology, Inc. Sell -3.12% 17.2%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.18% -3.46%
ILMN Illumina, Inc. Sell -3.79% 6.18%
VRDN Viridian Therapeutics, Inc. Sell -3.31% 12.58%
SGRY Surgery Partners, Inc. Sell -1.58% 8.09%
VKTX Viking Therapeutics, Inc. Sell -3.92% 10.85%
ICUI ICU Medical, Inc. Sell -4.6% -0.29%
TVTX Travere Therapeutics, Inc. Sell -4.8% -4.62%
The percentage of cash held in the portfolio is: 51.05%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 6.32% 1.85%
SENS Senseonics Holdings, Inc. Buy 6.72% -2.26%
INGN Inogen, Inc. Buy 8.85% 22.55%
SGMO Sangamo Therapeutics, Inc. Buy 10.04% 18.52%
ALT Altimmune, Inc. Buy 8.49% 9.74%
KIDS OrthoPediatrics Corp. Buy 7.95% 4.21%
GKOS Glaukos Corporation Buy 7.74% 2.57%
NUTX Nutex Health Inc. Buy 9.24% 7.38%
AORT Artivion, Inc. Buy 7.31% 13.52%
OMCL Omnicell, Inc. Buy 8.4% 7%
VCYT Veracyte, Inc. Buy 5.58% -3.91%
RCM R1 RCM Inc. Buy -2.01% -2.72%
ALGN Align Technology, Inc. Sell -3.17% 14.34%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.01% -1.2%
ILMN Illumina, Inc. Sell -3.77% 4.81%
VRDN Viridian Therapeutics, Inc. Sell -3.39% 8.7%
SGRY Surgery Partners, Inc. Sell -1.59% 5.27%
VKTX Viking Therapeutics, Inc. Sell -3.93% 8.76%
ICUI ICU Medical, Inc. Sell -4.57% -1.55%
TVTX Travere Therapeutics, Inc. Sell -4.87% -8.25%
The percentage of cash held in the portfolio is: 44.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -2.32%
ACRS Sell All -8.73%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 6.2% -0.79%
SENS Senseonics Holdings, Inc. Buy 6.68% -3.7%
INGN Inogen, Inc. Buy 9.05% 24.26%
ACRS Aclaris Therapeutics, Inc. Buy 6.88% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 9.65% 12.96%
ALT Altimmune, Inc. Buy 8.72% 11.82%
KIDS OrthoPediatrics Corp. Buy 7.86% 2.26%
GKOS Glaukos Corporation Buy 7.91% 4.04%
NUTX Nutex Health Inc. Buy 9.21% 6.21%
AORT Artivion, Inc. Buy 7.39% 13.76%
OMCL Omnicell, Inc. Buy 8.07% 1.99%
VCYT Veracyte, Inc. Buy 5.8% -0.89%
RCM R1 RCM Inc. Buy -2.04% -2.08%
PODD Insulet Corporation Buy 5.53% -0.67%
ALGN Align Technology, Inc. Sell -3.27% 12.26%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.13% -3.2%
ILMN Illumina, Inc. Sell -3.85% 3.8%
VRDN Viridian Therapeutics, Inc. Sell -3.64% 2.73%
SGRY Surgery Partners, Inc. Sell -1.62% 4.21%
VKTX Viking Therapeutics, Inc. Sell -4.25% 2.24%
ICUI ICU Medical, Inc. Sell -4.5% 0.72%
TVTX Travere Therapeutics, Inc. Sell -4.62% -1.82%
The percentage of cash held in the portfolio is: 32.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTCT Sell All 40.43%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.46% 15.84%
CARA Cara Therapeutics, Inc. Buy 6.24% -0.79%
SENS Senseonics Holdings, Inc. Buy 6.95% -0.41%
INGN Inogen, Inc. Buy 9.17% 25.25%
ACRS Aclaris Therapeutics, Inc. Buy 6.92% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 10.34% 20.37%
ALT Altimmune, Inc. Buy 8.74% 11.4%
KIDS OrthoPediatrics Corp. Buy 7.79% 0.66%
GKOS Glaukos Corporation Buy 8% 4.53%
NUTX Nutex Health Inc. Buy 9.14% 4.74%
AORT Artivion, Inc. Buy 7.32% 12.09%
OMCL Omnicell, Inc. Buy 8.04% 1.03%
VCYT Veracyte, Inc. Buy 5.99% 1.69%
RCM R1 RCM Inc. Buy -2.08% -0.56%
PODD Insulet Corporation Buy 5.66% 1.02%
ALGN Align Technology, Inc. Sell -3.34% 10.93%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.04% -0.53%
ILMN Illumina, Inc. Sell -3.96% 1.55%
VRDN Viridian Therapeutics, Inc. Sell -3.64% 3.31%
SGRY Surgery Partners, Inc. Sell -1.66% 2.86%
VKTX Viking Therapeutics, Inc. Sell -4.24% 2.98%
ICUI ICU Medical, Inc. Sell -4.56% 0%
TVTX Travere Therapeutics, Inc. Sell -4.56% 0%
The percentage of cash held in the portfolio is: 25.33%
New Assets Added
  • ICUI
  • TVTX
Assets Removed
Asset Action Perf %
IBRX Sell All -14.91%
RYTM Sell All -8.38%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.55% 19.11%
IBRX ImmunityBio, Inc. Buy 6.87% -13.79%
CARA Cara Therapeutics, Inc. Buy 6.61% 6.48%
SENS Senseonics Holdings, Inc. Buy 6.95% 1.03%
INGN Inogen, Inc. Buy 9.17% 26.95%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.43% -5.45%
ACRS Aclaris Therapeutics, Inc. Buy 6.76% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 9.57% 12.96%
ALT Altimmune, Inc. Buy 9.58% 23.78%
KIDS OrthoPediatrics Corp. Buy 7.62% -0.06%
GKOS Glaukos Corporation Buy 7.93% 5.12%
NUTX Nutex Health Inc. Buy 9.33% 8.41%
AORT Artivion, Inc. Buy 7.23% 12.28%
OMCL Omnicell, Inc. Buy 8.25% 5.08%
VCYT Veracyte, Inc. Buy 6.04% 4%
RCM R1 RCM Inc. Buy -2.03% -1.52%
PODD Insulet Corporation Buy 5.52% 0%
ALGN Align Technology, Inc. Sell -3.32% 10.26%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.15% -4.53%
ILMN Illumina, Inc. Sell -4.02% -1.45%
VRDN Viridian Therapeutics, Inc. Sell -3.9% -5.18%
SGRY Surgery Partners, Inc. Sell -1.67% 0.53%
VKTX Viking Therapeutics, Inc. Sell -4.31% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VKTX
  • PODD
Assets Removed
Asset Action Perf %
NVRO Buy All 1.33%
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.52% 17.82%
IBRX ImmunityBio, Inc. Buy 7.23% -9.9%
CARA Cara Therapeutics, Inc. Buy 6.28% 0.53%
SENS Senseonics Holdings, Inc. Buy 7.05% 1.85%
INGN Inogen, Inc. Buy 9.11% 25.39%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.56% -4.42%
ACRS Aclaris Therapeutics, Inc. Buy 6.81% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 9.16% 7.41%
ALT Altimmune, Inc. Buy 9.61% 23.37%
KIDS OrthoPediatrics Corp. Buy 7.57% -1.38%
GKOS Glaukos Corporation Buy 8.05% 6.06%
NUTX Nutex Health Inc. Buy 9.15% 5.62%
AORT Artivion, Inc. Buy 7.35% 13.38%
OMCL Omnicell, Inc. Buy 7.83% -0.86%
MD Pediatrix Medical Group, Inc. Buy 5.61% -3.87%
VCYT Veracyte, Inc. Buy 6.11% 4.67%
RCM R1 RCM Inc. Buy -2.08% 0%
NVRO Nevro Corp. Sell -3.88% 6.71%
ALGN Align Technology, Inc. Sell -3.42% 8.04%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.99% 0.13%
ILMN Illumina, Inc. Sell -4.07% -1.94%
VRDN Viridian Therapeutics, Inc. Sell -3.83% -2.59%
SGRY Surgery Partners, Inc. Sell -1.72% -1.81%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
FOLD Buy All -6.86%
ITGR Buy All -7.43%
WST Sell All -4.6%
Assets Rebalanced
None
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.29% 10.96%
IBRX ImmunityBio, Inc. Buy 7.89% -4%
CARA Cara Therapeutics, Inc. Buy 6.34% -0.79%
SENS Senseonics Holdings, Inc. Buy 6.46% -8.83%
INGN Inogen, Inc. Buy 9.31% 25.04%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.86% -2.97%
ACRS Aclaris Therapeutics, Inc. Buy 6.97% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 8.89% 1.85%
WST West Pharmaceutical Services, Inc. Buy 7.4% -2.79%
ALT Altimmune, Inc. Buy 8.18% 2.5%
KIDS OrthoPediatrics Corp. Buy 7.69% -2.14%
GKOS Glaukos Corporation Buy 8.02% 3.17%
NUTX Nutex Health Inc. Buy 9.12% 2.82%
AORT Artivion, Inc. Buy 7.36% 10.85%
OMCL Omnicell, Inc. Buy 8.27% 2.22%
MD Pediatrix Medical Group, Inc. Buy 5.98% 0%
VCYT Veracyte, Inc. Buy 5.98% 0%
ITGR Integer Holdings Corporation Sell -4.38% -2.84%
NVRO Nevro Corp. Sell -3.84% 9.98%
ALGN Align Technology, Inc. Sell -3.41% 10.52%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.2% -2.8%
ILMN Illumina, Inc. Sell -4.08% 0.04%
VRDN Viridian Therapeutics, Inc. Sell -3.94% -3.09%
SGRY Surgery Partners, Inc. Sell -1.69% 2.67%
FOLD Amicus Therapeutics, Inc. Sell -4.46% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • FOLD
  • MD
  • VCYT
Assets Removed
Asset Action Perf %
MD Buy All -0.35%
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.48% 12.88%
IBRX ImmunityBio, Inc. Buy 7.51% -9.68%
CARA Cara Therapeutics, Inc. Buy 6.13% -5.29%
SENS Senseonics Holdings, Inc. Buy 6.87% -4.31%
INGN Inogen, Inc. Buy 9.05% 20%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.75% -5.53%
ACRS Aclaris Therapeutics, Inc. Buy 7% -7.14%
SGMO Sangamo Therapeutics, Inc. Buy 9.17% 3.7%
WST West Pharmaceutical Services, Inc. Buy 7.62% -1.16%
ALT Altimmune, Inc. Buy 8.11% 0.42%
KIDS OrthoPediatrics Corp. Buy 7.78% -2.26%
GKOS Glaukos Corporation Buy 8.28% 5.17%
NUTX Nutex Health Inc. Buy 8.34% -7.18%
AORT Artivion, Inc. Buy 7.56% 12.42%
OMCL Omnicell, Inc. Buy 8.19% -0.03%
ITGR Integer Holdings Corporation Sell -4.49% -4.01%
NVRO Nevro Corp. Sell -3.73% 13.52%
ALGN Align Technology, Inc. Sell -3.44% 10.87%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.29% -3.73%
ILMN Illumina, Inc. Sell -4.06% 2.03%
MD Pediatrix Medical Group, Inc. Sell -4.36% 3.29%
VRDN Viridian Therapeutics, Inc. Sell -3.87% 0.07%
SGRY Surgery Partners, Inc. Sell -1.76% 0%
The percentage of cash held in the portfolio is: 14.15%
New Assets Added
  • SGRY
Assets Removed
Asset Action Perf %
FATE Buy All 34.93%
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.09% 8.68%
IBRX ImmunityBio, Inc. Buy 7.28% -10.34%
CARA Cara Therapeutics, Inc. Buy 6.35% 0.53%
SENS Senseonics Holdings, Inc. Buy 6.92% -1.23%
INGN Inogen, Inc. Buy 9.07% 23.26%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.44% -7.07%
ACRS Aclaris Therapeutics, Inc. Buy 7.15% -2.78%
SGMO Sangamo Therapeutics, Inc. Buy 8.31% -3.7%
IOVA Iovance Biotherapeutics, Inc. Buy 6.84% 7.6%
WST West Pharmaceutical Services, Inc. Buy 7.47% -0.78%
ALT Altimmune, Inc. Buy 8.47% 7.37%
KIDS OrthoPediatrics Corp. Buy 8.18% 5.28%
GKOS Glaukos Corporation Buy 7.87% 2.47%
NUTX Nutex Health Inc. Buy 8.51% -2.91%
AORT Artivion, Inc. Buy 7.34% 11.8%
OMCL Omnicell, Inc. Buy 8.03% 0.4%
FATE Fate Therapeutics, Inc. Sell -2.06% 37.8%
ITGR Integer Holdings Corporation Sell -4.39% -4.24%
NVRO Nevro Corp. Sell -3.91% 7.16%
ALGN Align Technology, Inc. Sell -3.46% 8.01%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.17% -3.2%
ILMN Illumina, Inc. Sell -3.99% 1.3%
MD Pediatrix Medical Group, Inc. Sell -4.23% 3.88%
VRDN Viridian Therapeutics, Inc. Sell -3.78% 0%
The percentage of cash held in the portfolio is: 8.69%
New Assets Added
  • VRDN
Assets Removed
Asset Action Perf %
ACHC Buy All -6.61%
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.19% 9%
IBRX ImmunityBio, Inc. Buy 7.26% -11.9%
CDMO Avid Bioservices, Inc. Buy 7.12% 10.85%
CARA Cara Therapeutics, Inc. Buy 6.22% -3.04%
SENS Senseonics Holdings, Inc. Buy 6.95% -2.26%
INGN Inogen, Inc. Buy 8.72% 16.88%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.63% -6.06%
ACRS Aclaris Therapeutics, Inc. Buy 7.23% -3.17%
SGMO Sangamo Therapeutics, Inc. Buy 8.11% -7.41%
IOVA Iovance Biotherapeutics, Inc. Buy 6.9% 7.12%
WST West Pharmaceutical Services, Inc. Buy 7.6% -0.49%
ALT Altimmune, Inc. Buy 7.97% -0.42%
KIDS OrthoPediatrics Corp. Buy 8.22% 4.31%
GKOS Glaukos Corporation Buy 7.94% 1.79%
NUTX Nutex Health Inc. Buy 8.47% -4.82%
AORT Artivion, Inc. Buy 7.41% 11.32%
OMCL Omnicell, Inc. Buy 8.07% -0.56%
FATE Fate Therapeutics, Inc. Sell -1.99% 40.99%
ITGR Integer Holdings Corporation Sell -4.41% -3.25%
NVRO Nevro Corp. Sell -3.84% 10.25%
ALGN Align Technology, Inc. Sell -3.43% 10.23%
ACHC Acadia Healthcare Company, Inc. Sell -3.69% 0.09%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.15% -1.33%
ILMN Illumina, Inc. Sell -4.02% 1.95%
MD Pediatrix Medical Group, Inc. Sell -4.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
Assets Removed
None
Assets Rebalanced
Asset Action Weight
KIDS Buy 0.38%
GKOS Buy 0.55%
SGMO Buy 0.62%
OMCL Buy 1.28%
2024-05-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.22% 11.27%
IBRX ImmunityBio, Inc. Buy 7.44% -8.12%
CDMO Avid Bioservices, Inc. Buy 7.32% 15.87%
CARA Cara Therapeutics, Inc. Buy 6.6% 4.76%
SENS Senseonics Holdings, Inc. Buy 7.19% 2.87%
SGMO Sangamo Therapeutics, Inc. Buy 7.34% 0%
INGN Inogen, Inc. Buy 7.6% 3.55%
ACRS Aclaris Therapeutics, Inc. Buy 7.81% 6.35%
IOVA Iovance Biotherapeutics, Inc. Buy 7.09% 11.84%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.59% -5.02%
KIDS OrthoPediatrics Corp. Buy 7.36% 9.09%
WST West Pharmaceutical Services, Inc. Buy 7.51% -0.03%
GKOS Glaukos Corporation Buy 6.93% 2.81%
ALT Altimmune, Inc. Buy 7.95% 1.11%
AORT Artivion, Inc. Buy 7.43% 13.57%
OMCL Omnicell, Inc. Buy 6.75% 0.56%
NUTX Nutex Health Inc. Buy 7.84% -10.41%
FATE Fate Therapeutics, Inc. Sell -2.05% 38.12%
ITGR Integer Holdings Corporation Sell -4.34% -3.25%
NVRO Nevro Corp. Sell -4.28% -1.86%
ALGN Align Technology, Inc. Sell -3.53% 6%
ACHC Acadia Healthcare Company, Inc. Sell -3.71% -1.98%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.03% 0%
ILMN Illumina, Inc. Sell -4.03% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
  • ILMN
Assets Removed
Asset Action Perf %
OFIX Buy All -6.93%
Assets Rebalanced
Asset Action Weight
ALT Buy 0.47%
NUTX Buy 0.6%
RYTM Buy 1.28%
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.49% 15.37%
CARA Cara Therapeutics, Inc. Buy 6.63% 4.5%
CDMO Avid Bioservices, Inc. Buy 7.08% 11.38%
IBRX ImmunityBio, Inc. Buy 7.08% -13.13%
SENS Senseonics Holdings, Inc. Buy 7.28% 3.49%
ACRS Aclaris Therapeutics, Inc. Buy 7.68% 3.97%
INGN Inogen, Inc. Buy 7.53% 1.99%
SGMO Sangamo Therapeutics, Inc. Buy 7.25% -1.85%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.08% 5.91%
IOVA Iovance Biotherapeutics, Inc. Buy 7.08% 11.04%
KIDS OrthoPediatrics Corp. Buy 7.17% 5.63%
ALT Altimmune, Inc. Buy 6.95% 2.36%
GKOS Glaukos Corporation Buy 6.79% -0.02%
WST West Pharmaceutical Services, Inc. Buy 7.52% -0.52%
NUTX Nutex Health Inc. Buy 7.45% -1%
OMCL Omnicell, Inc. Buy 6.72% -0.5%
AORT Artivion, Inc. Buy 6.63% 0.67%
FATE Fate Therapeutics, Inc. Sell -2.24% 32.7%
OFIX Orthofix Medical Inc. Sell -4.38% -3.62%
ITGR Integer Holdings Corporation Sell -4.31% -1.96%
NVRO Nevro Corp. Sell -4.17% 1.5%
ALGN Align Technology, Inc. Sell -3.56% 5.72%
ACHC Acadia Healthcare Company, Inc. Sell -3.75% -2.51%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRI Buy All -10.12%
Assets Rebalanced
Asset Action Weight
CARA Sell -0.72%
OMCL Sell -0.76%
AORT Sell -0.94%
PTCT Sell -1.32%
RYTM Sell -0.74%
CDMO Sell -0.76%
IOVA Sell -1.12%
WST Buy 0.33%
IBRX Buy 0.97%
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.71% 15.54%
IBRX ImmunityBio, Inc. Buy 7.06% 1.78%
CDMO Avid Bioservices, Inc. Buy 7.57% 9.13%
CARA Cara Therapeutics, Inc. Buy 7.14% 2.94%
SENS Senseonics Holdings, Inc. Buy 7.19% 3.68%
INGN Inogen, Inc. Buy 7.38% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 7.86% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 7.94% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 7.49% 2.93%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.69% 5.62%
GKOS Glaukos Corporation Buy 6.78% 1.41%
WST West Pharmaceutical Services, Inc. Buy 6.63% -0.93%
KIDS OrthoPediatrics Corp. Buy 6.9% 3.21%
ALT Altimmune, Inc. Buy 6.79% 1.53%
OMCL Omnicell, Inc. Buy 7.41% 0%
NUTX Nutex Health Inc. Buy 7.41% 0%
AORT Artivion, Inc. Buy 7.41% 0%
FATE Fate Therapeutics, Inc. Sell -2.13% 35.25%
ATRI Atrion Corporation Sell -4.38% -5.05%
NVRO Nevro Corp. Sell -4.16% 0.27%
ITGR Integer Holdings Corporation Sell -4.23% -1.54%
OFIX Orthofix Medical Inc. Sell -4.37% -4.7%
ALGN Align Technology, Inc. Sell -3.52% 5.56%
ACHC Acadia Healthcare Company, Inc. Sell -3.61% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ACHC
  • OMCL
  • NUTX
  • AORT
Assets Removed
Asset Action Perf %
NUTX Buy All 30.35%
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.04% 17.68%
SMMT Summit Therapeutics Inc. Buy 7.18% 5.18%
IBRX ImmunityBio, Inc. Buy 7.09% -0.22%
CDMO Avid Bioservices, Inc. Buy 7.7% 8.47%
CARA Cara Therapeutics, Inc. Buy 7.25% 2.12%
SENS Senseonics Holdings, Inc. Buy 7.55% 6.37%
INGN Inogen, Inc. Buy 7.43% -0.28%
ACRS Aclaris Therapeutics, Inc. Buy 7.75% 3.97%
IOVA Iovance Biotherapeutics, Inc. Buy 7.68% 3.04%
SGMO Sangamo Therapeutics, Inc. Buy 7.18% -3.7%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.37% -1.09%
GKOS Glaukos Corporation Buy 6.85% 0%
WST West Pharmaceutical Services, Inc. Buy 6.85% 0%
KIDS OrthoPediatrics Corp. Buy 6.85% 0%
ALT Altimmune, Inc. Buy 6.85% 0%
NUTX Nutex Health Inc. Sell -2.22% 34.02%
FATE Fate Therapeutics, Inc. Sell -2.2% 34.61%
ATRI Atrion Corporation Sell -4.48% -5.05%
NVRO Nevro Corp. Sell -4.2% 1.5%
ITGR Integer Holdings Corporation Sell -4.28% -0.31%
OFIX Orthofix Medical Inc. Sell -4.35% -1.92%
ALGN Align Technology, Inc. Sell -3.59% 6%
The percentage of cash held in the portfolio is: 15.7%
New Assets Added
  • GKOS
  • WST
  • KIDS
  • ALT
Assets Removed
Asset Action Perf %
BKD Buy All -7.96%
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.18% 19.57%
SMMT Summit Therapeutics Inc. Buy 8.33% 21.76%
IBRX ImmunityBio, Inc. Buy 6.76% -5.01%
CDMO Avid Bioservices, Inc. Buy 7.22% 1.46%
CARA Cara Therapeutics, Inc. Buy 7.14% 0.4%
SENS Senseonics Holdings, Inc. Buy 6.76% -4.93%
INGN Inogen, Inc. Buy 7.47% 0%
ACRS Aclaris Therapeutics, Inc. Buy 7.47% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 7.47% 0%
SGMO Sangamo Therapeutics, Inc. Buy 7.47% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.47% 0%
NUTX Nutex Health Inc. Sell -2.09% 37.91%
BKD Brookdale Senior Living Inc. Sell -3.54% -5.26%
FATE Fate Therapeutics, Inc. Sell -2.2% 34.77%
ATRI Atrion Corporation Sell -4.62% -8.07%
NVRO Nevro Corp. Sell -3.93% 8.04%
ITGR Integer Holdings Corporation Sell -4.28% -0.18%
OFIX Orthofix Medical Inc. Sell -4.29% -0.31%
ALGN Align Technology, Inc. Sell -3.57% 6.66%
The percentage of cash held in the portfolio is: 46.8%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
  • RYTM
Assets Removed
Asset Action Perf %
OPK Sell All -3.05%
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.86% -6.87%
PTCT PTC Therapeutics, Inc. Buy 7.88% 12.53%
SMMT Summit Therapeutics Inc. Buy 7.13% 1.81%
IBRX ImmunityBio, Inc. Buy 6.47% -11.12%
CDMO Avid Bioservices, Inc. Buy 7.35% 0.93%
CARA Cara Therapeutics, Inc. Buy 7.25% -0.53%
SENS Senseonics Holdings, Inc. Buy 7.28% 0%
NUTX Nutex Health Inc. Sell -2.14% 38.01%
BKD Brookdale Senior Living Inc. Sell -3.52% -1.95%
FATE Fate Therapeutics, Inc. Sell -2.17% 37%
ATRI Atrion Corporation Sell -4.69% -7.16%
NVRO Nevro Corp. Sell -4.09% 6.54%
ITGR Integer Holdings Corporation Sell -4.46% -1.87%
OFIX Orthofix Medical Inc. Sell -4.38% -0.08%
ALGN Align Technology, Inc. Sell -3.62% 7.36%
The percentage of cash held in the portfolio is: 74.85%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 11.04% -5.34%
PTCT PTC Therapeutics, Inc. Buy 7.88% 12.5%
SMMT Summit Therapeutics Inc. Buy 7.04% 0.52%
IBRX ImmunityBio, Inc. Buy 7.29% 0%
CDMO Avid Bioservices, Inc. Buy 7.29% 0%
CARA Cara Therapeutics, Inc. Buy 7.29% 0%
NUTX Nutex Health Inc. Sell -2.21% 35.86%
BKD Brookdale Senior Living Inc. Sell -3.58% -3.75%
FATE Fate Therapeutics, Inc. Sell -2.22% 35.57%
ATRI Atrion Corporation Sell -4.66% -6.33%
NVRO Nevro Corp. Sell -4.42% -0.88%
ITGR Integer Holdings Corporation Sell -4.58% -4.55%
OFIX Orthofix Medical Inc. Sell -4.41% -0.77%
ALGN Align Technology, Inc. Sell -3.91% 0%
The percentage of cash held in the portfolio is: 82.17%
New Assets Added
  • ALGN
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 11.24% -3.82%
PTCT PTC Therapeutics, Inc. Buy 7.02% 0%
SMMT Summit Therapeutics Inc. Buy 7.02% 0%
NUTX Nutex Health Inc. Sell -2.35% 32.17%
BKD Brookdale Senior Living Inc. Sell -3.61% -4.5%
FATE Fate Therapeutics, Inc. Sell -2.1% 39.39%
ATRI Atrion Corporation Sell -4.39% 0%
NVRO Nevro Corp. Sell -4.39% 0%
ITGR Integer Holdings Corporation Sell -4.39% 0%
OFIX Orthofix Medical Inc. Sell -4.39% 0%
The percentage of cash held in the portfolio is: 100.32%
New Assets Added
  • ATRI
  • NVRO
  • ITGR
  • OFIX
  • PTCT
  • SMMT
Assets Removed
Asset Action Perf %
UTHR Buy All -1.8%
ANGO Sell All 1.93%
KIDS Sell All 4.45%
ACRS Sell All -4.76%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.64% 10.7%
KIDS OrthoPediatrics Corp. Buy 10.1% 5.11%
ACRS Aclaris Therapeutics, Inc. Buy 9.23% -3.97%
OPK OPKO Health, Inc. Buy 10.92% -6.11%
UTHR United Therapeutics Corporation Sell -5.99% -2.33%
NUTX Nutex Health Inc. Sell -1.88% 45.39%
BKD Brookdale Senior Living Inc. Sell -3.27% 5.11%
FATE Fate Therapeutics, Inc. Sell -3.1% 10.05%
The percentage of cash held in the portfolio is: 73.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -9.75%
Assets Rebalanced
None
2024-04-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.72% 11.75%
TNDM Tandem Diabetes Care, Inc. Buy 9.11% -5.1%
KIDS OrthoPediatrics Corp. Buy 10.3% 7.32%
ACRS Aclaris Therapeutics, Inc. Buy 9.21% -3.97%
OPK OPKO Health, Inc. Buy 10.9% -6.11%
UTHR United Therapeutics Corporation Sell -5.92% -1.25%
NUTX Nutex Health Inc. Sell -2.36% 31.25%
BKD Brookdale Senior Living Inc. Sell -3.34% 2.85%
FATE Fate Therapeutics, Inc. Sell -3.16% 7.97%
The percentage of cash held in the portfolio is: 64.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
RVNC Sell All -16.06%
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.49% 20.18%
TNDM Tandem Diabetes Care, Inc. Buy 9.37% -2.07%
KIDS OrthoPediatrics Corp. Buy 10.49% 9.67%
ACRS Aclaris Therapeutics, Inc. Buy 8.81% -7.94%
RVNC Revance Therapeutics, Inc. Buy 9.44% -10.37%
OPK OPKO Health, Inc. Buy 11.22% -3.05%
UTHR United Therapeutics Corporation Sell -6.03% -3.51%
NUTX Nutex Health Inc. Sell -3.42% 0%
BKD Brookdale Senior Living Inc. Sell -3.42% 0%
FATE Fate Therapeutics, Inc. Sell -3.42% 0%
The percentage of cash held in the portfolio is: 55.48%
New Assets Added
  • NUTX
  • BKD
  • FATE
Assets Removed
Asset Action Perf %
LXRX Sell All -15.83%
Assets Rebalanced
None
2024-04-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.48% 22.28%
TNDM Tandem Diabetes Care, Inc. Buy 9.28% -1.16%
KIDS OrthoPediatrics Corp. Buy 9.85% 4.94%
ACRS Aclaris Therapeutics, Inc. Buy 8.87% -5.56%
RVNC Revance Therapeutics, Inc. Buy 9.86% -4.67%
LXRX Lexicon Pharmaceuticals, Inc. Buy 8.92% -13.75%
OPK OPKO Health, Inc. Buy 11.97% 5.34%
UTHR United Therapeutics Corporation Sell -5.9% -3.19%
The percentage of cash held in the portfolio is: 35.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All -1111.05%
Assets Rebalanced
None
2024-04-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 7.21% 23.33%
TNDM Tandem Diabetes Care, Inc. Buy 5.57% -4.65%
KIDS OrthoPediatrics Corp. Buy 5.54% -5.18%
ACRS Aclaris Therapeutics, Inc. Buy 5.52% -5.56%
RVNC Revance Therapeutics, Inc. Buy 5.77% -10.37%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.53% -14.17%
OPK OPKO Health, Inc. Buy 7.29% 3.05%
UTHR United Therapeutics Corporation Sell -3.62% -1.67%
NUTX Nutex Health Inc. Sell -2.87% 16.84%
The percentage of cash held in the portfolio is: 64.06%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All 7.77%
BAX Sell All -0.86%
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 7.36% -0.19%
ANGO AngioDynamics, Inc. Buy 6.4% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 5.6% -5.1%
KIDS OrthoPediatrics Corp. Buy 5.43% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 5.71% -3.17%
RVNC Revance Therapeutics, Inc. Buy 5.96% -8.33%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.98% -7.92%
OPK OPKO Health, Inc. Buy 7.35% 3.05%
SMTI Sanara MedTech Inc. Sell -2.47% 4.29%
UTHR United Therapeutics Corporation Sell -3.58% 0.5%
NUTX Nutex Health Inc. Sell -3.45% 1.05%
The percentage of cash held in the portfolio is: 59.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Buy All 10.62%
OMCL Sell All -0.14%
VCYT Sell All -5.57%
NTRA Sell All 2.8%
THC Sell All 9.07%
RDNT Sell All 8.23%
BHVN Sell All -9.93%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 7.76% 3.97%
THC Tenet Healthcare Corporation Buy 7.87% 10.71%
RDNT RadNet, Inc. Buy 7.69% 8.48%
BHVN Biohaven Ltd. Buy 6.47% -7.68%
BAX Baxter International Inc. Buy 7.4% 1.3%
OMCL Omnicell, Inc. Buy 7.46% 3.02%
ANGO AngioDynamics, Inc. Buy 5.98% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 5.6% -4.11%
KIDS OrthoPediatrics Corp. Buy 5.69% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 5.84% 0%
VCYT Veracyte, Inc. Buy 5.82% -0.37%
RVNC Revance Therapeutics, Inc. Buy 6.19% -3.86%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.12% -5%
OPK OPKO Health, Inc. Buy 7.07% 0%
ORGO Organogenesis Holdings Inc. Sell -6.65% 4.11%
SMTI Sanara MedTech Inc. Sell -2.53% 0.92%
UTHR United Therapeutics Corporation Sell -3.54% 0.64%
NUTX Nutex Health Inc. Sell -3.46% 0%
The percentage of cash held in the portfolio is: 23.22%
New Assets Added
  • NUTX
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 7.47% 2.29%
THC Tenet Healthcare Corporation Buy 7.74% 11.48%
RDNT RadNet, Inc. Buy 7.61% 9.72%
BHVN Biohaven Ltd. Buy 6.64% -3.01%
BAX Baxter International Inc. Buy 7.1% -0.58%
OMCL Omnicell, Inc. Buy 7.44% 5.18%
ANGO AngioDynamics, Inc. Buy 5.88% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 5.73% 0.31%
KIDS OrthoPediatrics Corp. Buy 5.75% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 5.62% -1.59%
VCYT Veracyte, Inc. Buy 5.83% 2.03%
ATRI Atrion Corporation Buy 6.29% 0%
OFIX Orthofix Medical Inc. Buy 6.29% 0%
RVNC Revance Therapeutics, Inc. Buy 6.29% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.29% 0%
ORGO Organogenesis Holdings Inc. Sell -6.6% 2.74%
SMTI Sanara MedTech Inc. Sell -2.51% -0.57%
UTHR United Therapeutics Corporation Sell -3.48% 0%
The percentage of cash held in the portfolio is: 14.59%
New Assets Added
  • UTHR
  • ATRI
  • OFIX
  • RVNC
  • LXRX
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 7.38% 1.17%
THC Tenet Healthcare Corporation Buy 7.72% 11.22%
RDNT RadNet, Inc. Buy 7.57% 9.33%
BHVN Biohaven Ltd. Buy 6.92% 1.12%
BAX Baxter International Inc. Buy 7.09% -0.7%
OMCL Omnicell, Inc. Buy 7.44% 5.22%
ANGO AngioDynamics, Inc. Buy 5.71% 0%
TNDM Tandem Diabetes Care, Inc. Buy 5.71% 0%
KIDS OrthoPediatrics Corp. Buy 5.71% 0%
ACRS Aclaris Therapeutics, Inc. Buy 5.71% 0%
VCYT Veracyte, Inc. Buy 5.71% 0%
ORGO Organogenesis Holdings Inc. Sell -6.41% 5.48%
SMTI Sanara MedTech Inc. Sell -2.53% -1.39%
The percentage of cash held in the portfolio is: 36.26%
New Assets Added
  • ANGO
  • TNDM
  • KIDS
  • ACRS
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-03-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 7.56% 3.25%
THC Tenet Healthcare Corporation Buy 7.54% 8.23%
RDNT RadNet, Inc. Buy 7.53% 8.32%
BHVN Biohaven Ltd. Buy 6.81% -0.96%
BAX Baxter International Inc. Buy 6.99% -2.44%
OMCL Omnicell, Inc. Buy 7.13% 0.5%
ORGO Organogenesis Holdings Inc. Sell -6.08% 10.62%
SMTI Sanara MedTech Inc. Sell -2.55% -1.69%
The percentage of cash held in the portfolio is: 65.07%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Buy All 4.09%
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 7.62% 3.9%
THC Tenet Healthcare Corporation Buy 7.6% 8.8%
RDNT RadNet, Inc. Buy 7.42% 6.45%
BHVN Biohaven Ltd. Buy 7.25% 5.27%
BAX Baxter International Inc. Buy 6.98% -2.7%
OMCL Omnicell, Inc. Buy 7.15% 0.5%
TDOC Teladoc Health, Inc. Sell -3.56% 1.47%
ORGO Organogenesis Holdings Inc. Sell -6.54% 4.11%
SMTI Sanara MedTech Inc. Sell -2.57% -2.45%
The percentage of cash held in the portfolio is: 68.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
QTRX Sell All -9.55%
Assets Rebalanced
None
2024-03-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 7.5% 2.07%
THC Tenet Healthcare Corporation Buy 7.6% 8.73%
RDNT RadNet, Inc. Buy 7.16% 2.59%
BHVN Biohaven Ltd. Buy 6.96% 0.99%
QTRX Quanterix Corporation Buy 6.62% -3.95%
BAX Baxter International Inc. Buy 7.01% -2.42%
OMCL Omnicell, Inc. Buy 7.08% -0.54%
TDOC Teladoc Health, Inc. Sell -3.47% 3.9%
ORGO Organogenesis Holdings Inc. Sell -6.43% 5.82%
SMTI Sanara MedTech Inc. Sell -2.55% -1.22%
The percentage of cash held in the portfolio is: 62.51%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAGE Buy All 17.15%
SAVA Buy All -10.84%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 7.44% 0.79%
THC Tenet Healthcare Corporation Buy 7.48% 6.46%
RDNT RadNet, Inc. Buy 7.09% 1.08%
BHVN Biohaven Ltd. Buy 6.97% 0.62%
QTRX Quanterix Corporation Buy 6.56% -5.31%
BAX Baxter International Inc. Buy 6.98% -3.37%
OMCL Omnicell, Inc. Buy 7.07% -1.15%
SAGE Sage Therapeutics, Inc. Sell -4.13% 16.76%
TDOC Teladoc Health, Inc. Sell -3.51% 3.32%
ORGO Organogenesis Holdings Inc. Sell -6.46% 5.82%
SAVA Cassava Sciences, Inc. Sell -2.71% -7.26%
SMTI Sanara MedTech Inc. Sell -2.5% 1.03%
The percentage of cash held in the portfolio is: 69.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All -5.93%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 7.42% 0.12%
THC Tenet Healthcare Corporation Buy 7.39% 4.78%
RDNT RadNet, Inc. Buy 7.05% 0.23%
BHVN Biohaven Ltd. Buy 7.03% 1.21%
QTRX Quanterix Corporation Buy 6.57% -5.42%
BAX Baxter International Inc. Buy 7.01% -3.21%
OMCL Omnicell, Inc. Buy 7.15% -0.36%
ABUS Arbutus Biopharma Corporation Buy 6.54% -2.96%
SAGE Sage Therapeutics, Inc. Sell -4.28% 14.18%
TDOC Teladoc Health, Inc. Sell -3.52% 3.32%
ORGO Organogenesis Holdings Inc. Sell -6.72% 2.4%
SAVA Cassava Sciences, Inc. Sell -2.72% -7.31%
SMTI Sanara MedTech Inc. Sell -2.55% -0.57%
The percentage of cash held in the portfolio is: 63.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
BRKR Sell All 15.05%
RCM Sell All 21.04%
Assets Rebalanced
None
2024-03-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 7.62% 14.72%
RCM R1 RCM Inc. Buy 7.91% 22.38%
NTRA Natera, Inc. Buy 7.26% -1.9%
THC Tenet Healthcare Corporation Buy 7.47% 6.1%
RDNT RadNet, Inc. Buy 6.95% -1.08%
BHVN Biohaven Ltd. Buy 6.95% 0.05%
QTRX Quanterix Corporation Buy 6.53% -6.02%
BAX Baxter International Inc. Buy 7.08% -2.26%
OMCL Omnicell, Inc. Buy 7.13% -0.72%
ABUS Arbutus Biopharma Corporation Buy 6.51% -3.33%
SAGE Sage Therapeutics, Inc. Sell -4.24% 14.87%
TDOC Teladoc Health, Inc. Sell -3.46% 5.12%
ORGO Organogenesis Holdings Inc. Sell -6.69% 2.74%
SAVA Cassava Sciences, Inc. Sell -2.64% -4.28%
SMTI Sanara MedTech Inc. Sell -2.51% 1.17%
The percentage of cash held in the portfolio is: 48.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -15.74%
Assets Rebalanced
None
2024-03-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 7.57% 15.68%
RCM R1 RCM Inc. Buy 7.95% 24.89%
NTRA Natera, Inc. Buy 7.26% -0.5%
THC Tenet Healthcare Corporation Buy 7.39% 6.46%
RDNT RadNet, Inc. Buy 7.03% 1.53%
MRSN Mersana Therapeutics, Inc. Buy 6.57% -3.37%
BHVN Biohaven Ltd. Buy 7.25% 5.96%
QTRX Quanterix Corporation Buy 6.42% -6.27%
BAX Baxter International Inc. Buy 7.08% -0.72%
OMCL Omnicell, Inc. Buy 7.06% -0.11%
ABUS Arbutus Biopharma Corporation Buy 6.63% 0%
SAGE Sage Therapeutics, Inc. Sell -4.35% 11.43%
TDOC Teladoc Health, Inc. Sell -3.48% 3.2%
ORGO Organogenesis Holdings Inc. Sell -6.96% -2.74%
SAVA Cassava Sciences, Inc. Sell -2.6% -4.08%
SMTI Sanara MedTech Inc. Sell -2.53% -1.39%
The percentage of cash held in the portfolio is: 41.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMI Sell All 16.12%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMI Owens & Minor, Inc. Buy 6.45% 16.3%
BRKR Bruker Corporation Buy 7.55% 15.83%
RCM R1 RCM Inc. Buy 7.96% 25.69%
NTRA Natera, Inc. Buy 7.37% 1.57%
THC Tenet Healthcare Corporation Buy 7.33% 6.01%
RDNT RadNet, Inc. Buy 7.16% 3.77%
MRSN Mersana Therapeutics, Inc. Buy 6.43% -5.05%
BHVN Biohaven Ltd. Buy 7.08% 3.88%
QTRX Quanterix Corporation Buy 6.51% -4.49%
BAX Baxter International Inc. Buy 7.09% -0.23%
OMCL Omnicell, Inc. Buy 7.11% 1.04%
ABUS Arbutus Biopharma Corporation Buy 6.58% -0.37%
SAGE Sage Therapeutics, Inc. Sell -4.27% 12.55%
TDOC Teladoc Health, Inc. Sell -3.51% 1.73%
ORGO Organogenesis Holdings Inc. Sell -6.79% -0.68%
SAVA Cassava Sciences, Inc. Sell -2.61% -4.89%
SMTI Sanara MedTech Inc. Sell -2.49% -0.16%
The percentage of cash held in the portfolio is: 35.06%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Sell All -5.28%
FATE Sell All 21.78%
APLS Sell All -9.48%
Assets Rebalanced
None
2024-03-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 7.02% 25.44%
OMI Owens & Minor, Inc. Buy 6.5% 17.32%
BRKR Bruker Corporation Buy 7.44% 14.38%
RCM R1 RCM Inc. Buy 7.95% 25.69%
NTRA Natera, Inc. Buy 7.24% -0.15%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.07% -1.76%
THC Tenet Healthcare Corporation Buy 7.1% 2.95%
RDNT RadNet, Inc. Buy 7.18% 4.24%
MRSN Mersana Therapeutics, Inc. Buy 6.48% -4.21%
BHVN Biohaven Ltd. Buy 6.68% -1.79%
QTRX Quanterix Corporation Buy 6.39% -6.13%
APLS Apellis Pharmaceuticals, Inc. Buy 6.39% -6.1%
BAX Baxter International Inc. Buy 7.17% 1.14%
OMCL Omnicell, Inc. Buy 7.15% 1.76%
ABUS Arbutus Biopharma Corporation Buy 6.64% 0.74%
SAGE Sage Therapeutics, Inc. Sell -4.44% 8.98%
TDOC Teladoc Health, Inc. Sell -3.56% 0.32%
ORGO Organogenesis Holdings Inc. Sell -6.88% -2.05%
SAVA Cassava Sciences, Inc. Sell -2.31% 7.06%
SMTI Sanara MedTech Inc. Sell -2.46% 0.79%
The percentage of cash held in the portfolio is: 15.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
INO Buy All -33.33%
ACRS Sell All 3.2%
Assets Rebalanced
None
2024-03-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 7.09% 29.09%
OMI Owens & Minor, Inc. Buy 6.46% 18.76%
BRKR Bruker Corporation Buy 7.28% 13.88%
RCM R1 RCM Inc. Buy 7.72% 24.26%
NTRA Natera, Inc. Buy 7.09% -0.39%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.09% 0.33%
THC Tenet Healthcare Corporation Buy 7.09% 4.66%
RDNT RadNet, Inc. Buy 7.09% 4.87%
MRSN Mersana Therapeutics, Inc. Buy 6.46% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 7.54% 12.8%
BHVN Biohaven Ltd. Buy 6.87% 2.8%
QTRX Quanterix Corporation Buy 6.32% -5.45%
APLS Apellis Pharmaceuticals, Inc. Buy 6.37% -4.64%
BAX Baxter International Inc. Buy 7.09% 1.81%
OMCL Omnicell, Inc. Buy 7.09% 2.73%
ABUS Arbutus Biopharma Corporation Buy 6.55% 1.11%
SAGE Sage Therapeutics, Inc. Sell -4.55% 5.07%
TDOC Teladoc Health, Inc. Sell -3.46% 1.41%
ORGO Organogenesis Holdings Inc. Sell -7.05% -6.51%
SAVA Cassava Sciences, Inc. Sell -2.31% 5.34%
SMTI Sanara MedTech Inc. Sell -2.42% 0.73%
INO Inovio Pharmaceuticals, Inc. Sell -2.79% -12.74%
The percentage of cash held in the portfolio is: 11.35%
New Assets Added
None
Assets Removed
Asset Action Perf %
CTLT Buy All -0.02%
HAE Buy All -7.29%
NUTX Sell All -17.21%
Assets Rebalanced
Asset Action Weight
OMI Sell -1.23%
MRSN Sell -1.35%
NTRA Sell -0.9%
ENTA Sell -0.96%
THC Sell -1.31%
RDNT Sell -1.33%
FATE Sell -1.52%
BAX Sell -1.75%
OMCL Sell -1.83%
2024-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 8.7% 32.75%
OMI Owens & Minor, Inc. Buy 7.52% 18.3%
BRKR Bruker Corporation Buy 7.22% 15.17%
NUTX Nutex Health Inc. Buy 5.76% -13.11%
RCM R1 RCM Inc. Buy 7.75% 27.04%
THC Tenet Healthcare Corporation Buy 8.2% 4.1%
MRSN Mersana Therapeutics, Inc. Buy 7.76% -1.52%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.07% 2.41%
RDNT RadNet, Inc. Buy 8.62% 9.45%
NTRA Natera, Inc. Buy 8.08% 2.52%
QTRX Quanterix Corporation Buy 6.55% -0.07%
BHVN Biohaven Ltd. Buy 6.75% 2.94%
ACRS Aclaris Therapeutics, Inc. Buy 7.08% 8%
APLS Apellis Pharmaceuticals, Inc. Buy 6.34% -3.39%
BAX Baxter International Inc. Buy 8.62% 1.16%
OMCL Omnicell, Inc. Buy 8.61% 0.97%
ABUS Arbutus Biopharma Corporation Buy 6.36% 0%
CTLT Catalent, Inc. Sell -4.11% 0.25%
HAE Haemonetics Corporation Sell -4.09% -4.78%
SAGE Sage Therapeutics, Inc. Sell -4.32% 8.17%
TDOC Teladoc Health, Inc. Sell -3.38% 1.85%
ORGO Organogenesis Holdings Inc. Sell -6.96% -7.19%
SMTI Sanara MedTech Inc. Sell -2.4% -0.11%
SAVA Cassava Sciences, Inc. Sell -2.32% 2.97%
INO Inovio Pharmaceuticals, Inc. Sell -2.43% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INO
  • ABUS
Assets Removed
Asset Action Perf %
GKOS Buy All 4.98%
ATRI Sell All 18.86%
Assets Rebalanced
None
2024-03-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 6.8% 13.11%
FATE Fate Therapeutics, Inc. Buy 8.35% 26.87%
OMI Owens & Minor, Inc. Buy 7.32% 14.5%
BRKR Bruker Corporation Buy 7.13% 13.09%
NUTX Nutex Health Inc. Buy 5.85% -12.3%
RCM R1 RCM Inc. Buy 7.64% 24.71%
THC Tenet Healthcare Corporation Buy 8.17% 3.23%
MRSN Mersana Therapeutics, Inc. Buy 7.65% -3.37%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.08% 2.02%
RDNT RadNet, Inc. Buy 8.66% 9.36%
NTRA Natera, Inc. Buy 7.99% 0.91%
QTRX Quanterix Corporation Buy 6.64% 0.75%
BHVN Biohaven Ltd. Buy 6.79% 3.09%
ACRS Aclaris Therapeutics, Inc. Buy 7.59% 15.2%
APLS Apellis Pharmaceuticals, Inc. Buy 6.21% -5.71%
BAX Baxter International Inc. Buy 8.56% 0%
OMCL Omnicell, Inc. Buy 8.56% 0%
CTLT Catalent, Inc. Sell -4.15% -0.27%
HAE Haemonetics Corporation Sell -4.09% -4.38%
GKOS Glaukos Corporation Sell -3.07% 8.62%
SAGE Sage Therapeutics, Inc. Sell -4.29% 9.2%
TDOC Teladoc Health, Inc. Sell -3.22% 6.78%
ORGO Organogenesis Holdings Inc. Sell -6.37% 2.4%
SMTI Sanara MedTech Inc. Sell -2.4% 0%
SAVA Cassava Sciences, Inc. Sell -2.4% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • SAVA
  • BAX
  • OMCL
Assets Removed
Asset Action Perf %
TVTX Buy All -4.24%
NVTA Buy All 83.05%
Assets Rebalanced
None
2024-03-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 7.22% 17.92%
FATE Fate Therapeutics, Inc. Buy 7.39% 10.17%
OMI Owens & Minor, Inc. Buy 7.42% 14.03%
BRKR Bruker Corporation Buy 7.23% 12.64%
NUTX Nutex Health Inc. Buy 6.01% -11.48%
RCM R1 RCM Inc. Buy 7.81% 25.07%
THC Tenet Healthcare Corporation Buy 8.18% 1.35%
MRSN Mersana Therapeutics, Inc. Buy 7.84% -2.86%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.92% -1.89%
RDNT RadNet, Inc. Buy 8.63% 6.94%
NTRA Natera, Inc. Buy 7.91% -2%
QTRX Quanterix Corporation Buy 6.75% 0.5%
BHVN Biohaven Ltd. Buy 6.99% 4.01%
ACRS Aclaris Therapeutics, Inc. Buy 6.82% 1.6%
APLS Apellis Pharmaceuticals, Inc. Buy 6.49% -3.34%
TVTX Travere Therapeutics, Inc. Sell -3.24% 2.66%
NVTA Invitae Corporation Sell -0.58% 82.49%
CTLT Catalent, Inc. Sell -4.25% -0.81%
HAE Haemonetics Corporation Sell -4.12% -3.1%
GKOS Glaukos Corporation Sell -3.09% 9.9%
SAGE Sage Therapeutics, Inc. Sell -4.39% 8.77%
TDOC Teladoc Health, Inc. Sell -3.24% 7.99%
ORGO Organogenesis Holdings Inc. Sell -6.33% 4.79%
The percentage of cash held in the portfolio is: 18.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
NTLA Sell All 19.61%
RGNX Sell All 68.91%
Assets Rebalanced
None
2024-03-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 8.39% 28.07%
ATRI Atrion Corporation Buy 6.9% 11.54%
RGNX REGENXBIO Inc. Buy 7.7% 46.6%
FATE Fate Therapeutics, Inc. Buy 7.62% 12.56%
OMI Owens & Minor, Inc. Buy 7.6% 15.7%
BRKR Bruker Corporation Buy 7.29% 12.49%
NUTX Nutex Health Inc. Buy 6.41% -6.56%
RCM R1 RCM Inc. Buy 7.89% 25.25%
THC Tenet Healthcare Corporation Buy 8.09% -0.63%
MRSN Mersana Therapeutics, Inc. Buy 7.88% -3.2%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.3% 1.95%
RDNT RadNet, Inc. Buy 8.6% 5.61%
NTRA Natera, Inc. Buy 8.22% 0.89%
QTRX Quanterix Corporation Buy 6.78% 0%
BHVN Biohaven Ltd. Buy 6.78% 0%
ACRS Aclaris Therapeutics, Inc. Buy 6.78% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 6.78% 0%
TVTX Travere Therapeutics, Inc. Sell -3.33% 0.85%
NVTA Invitae Corporation Sell -0.63% 81.37%
CTLT Catalent, Inc. Sell -4.29% -0.8%
HAE Haemonetics Corporation Sell -4.06% -0.78%
GKOS Glaukos Corporation Sell -3.27% 5.35%
SAGE Sage Therapeutics, Inc. Sell -4.55% 6.45%
TDOC Teladoc Health, Inc. Sell -3.35% 5.82%
ORGO Organogenesis Holdings Inc. Sell -6.62% 1.37%
The percentage of cash held in the portfolio is: 2.09%
New Assets Added
  • QTRX
  • BHVN
  • ACRS
  • APLS
Assets Removed
Asset Action Perf %
CERS Sell All -7.83%
CHRS Sell All -13.36%
RVNC Sell All -14.99%
Assets Rebalanced
None
2024-03-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 8.38% 29.14%
ATRI Atrion Corporation Buy 6.31% 3.03%
RGNX REGENXBIO Inc. Buy 7.57% 45.44%
CERS Cerus Corporation Buy 6.52% -5.22%
FATE Fate Therapeutics, Inc. Buy 8.26% 23.05%
CHRS Coherus BioSciences, Inc. Buy 6.25% -8.02%
OMI Owens & Minor, Inc. Buy 7.43% 14.13%
BRKR Bruker Corporation Buy 7.09% 10.34%
NUTX Nutex Health Inc. Buy 6.29% -7.38%
RCM R1 RCM Inc. Buy 7.83% 25.34%
RVNC Revance Therapeutics, Inc. Buy 7.64% -2.24%
THC Tenet Healthcare Corporation Buy 8.07% 0%
MRSN Mersana Therapeutics, Inc. Buy 8.07% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.07% 0%
RDNT RadNet, Inc. Buy 8.07% 0%
NTRA Natera, Inc. Buy 8.07% 0%
TVTX Travere Therapeutics, Inc. Sell -3.17% 4.72%
NVTA Invitae Corporation Sell -0.76% 77.1%
CTLT Catalent, Inc. Sell -4.27% -1.22%
HAE Haemonetics Corporation Sell -3.99% 0.05%
GKOS Glaukos Corporation Sell -3.25% 5.08%
SAGE Sage Therapeutics, Inc. Sell -4.52% 6.06%
TDOC Teladoc Health, Inc. Sell -3.38% 4.09%
ORGO Organogenesis Holdings Inc. Sell -6.65% 0%
The percentage of cash held in the portfolio is: 10.07%
New Assets Added
  • ORGO
  • THC
  • MRSN
  • ENTA
  • RDNT
  • NTRA
Assets Removed
Asset Action Perf %
MCRB Buy All -20.59%
Assets Rebalanced
None
2024-03-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 8.37% 27.01%
ATRI Atrion Corporation Buy 6.57% 5.65%
RGNX REGENXBIO Inc. Buy 6.32% 19.7%
CERS Cerus Corporation Buy 6.62% -5.22%
FATE Fate Therapeutics, Inc. Buy 7.67% 12.72%
CHRS Coherus BioSciences, Inc. Buy 6% -12.98%
OMI Owens & Minor, Inc. Buy 7.45% 12.69%
BRKR Bruker Corporation Buy 7.05% 8.11%
NUTX Nutex Health Inc. Buy 6.39% -7.38%
RCM R1 RCM Inc. Buy 7.97% 25.78%
RVNC Revance Therapeutics, Inc. Buy 7.93% 0%
TVTX Travere Therapeutics, Inc. Sell -3.09% 8.47%
NVTA Invitae Corporation Sell -0.46% 86.42%
CTLT Catalent, Inc. Sell -4.34% -1.49%
MCRB Seres Therapeutics, Inc. Sell -4.78% -11.76%
HAE Haemonetics Corporation Sell -3.99% 1.64%
GKOS Glaukos Corporation Sell -3.29% 5.32%
SAGE Sage Therapeutics, Inc. Sell -4.51% 7.69%
TDOC Teladoc Health, Inc. Sell -3.45% 3.58%
The percentage of cash held in the portfolio is: 49.57%
New Assets Added
  • RVNC
Assets Removed
Asset Action Perf %
CARA Sell All 32.4%
NVAX Sell All 14.88%
VRDN Sell All -7.24%
Assets Rebalanced
None
2024-02-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 8.45% 29.7%
ATRI Atrion Corporation Buy 6.4% 4.21%
RGNX REGENXBIO Inc. Buy 7.13% 36.58%
CERS Cerus Corporation Buy 6.6% -4.35%
FATE Fate Therapeutics, Inc. Buy 7.64% 13.51%
CHRS Coherus BioSciences, Inc. Buy 6.14% -9.92%
OMI Owens & Minor, Inc. Buy 7.58% 15.98%
BRKR Bruker Corporation Buy 6.96% 8.03%
NUTX Nutex Health Inc. Buy 6.26% -8.2%
NVAX Novavax, Inc. Buy 7.54% 2.56%
RCM R1 RCM Inc. Buy 8.07% 28.83%
CARA Cara Therapeutics, Inc. Buy 8.68% 38.63%
VRDN Viridian Therapeutics, Inc. Buy 7.73% 0%
TVTX Travere Therapeutics, Inc. Sell -3.15% 5.69%
NVTA Invitae Corporation Sell -0.42% 87.54%
CTLT Catalent, Inc. Sell -4.34% -2.55%
MCRB Seres Therapeutics, Inc. Sell -4.77% -12.75%
HAE Haemonetics Corporation Sell -4.04% -0.9%
GKOS Glaukos Corporation Sell -3.31% 3.77%
SAGE Sage Therapeutics, Inc. Sell -4.68% 3.09%
TDOC Teladoc Health, Inc. Sell -3.41% 3.52%
The percentage of cash held in the portfolio is: 32.93%
New Assets Added
  • VRDN
Assets Removed
Asset Action Perf %
ACRS Sell All -3.25%
CUTR Sell All -32.07%
MYGN Sell All -8.39%
INGN Sell All -38.03%
Assets Rebalanced
None
2024-02-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 7.39% 22.66%
ATRI Atrion Corporation Buy 5.73% 0.86%
RGNX REGENXBIO Inc. Buy 6.63% 37.41%
CERS Cerus Corporation Buy 6.33% -0.87%
FATE Fate Therapeutics, Inc. Buy 7.38% 18.6%
CHRS Coherus BioSciences, Inc. Buy 6.3% 0%
ACRS Aclaris Therapeutics, Inc. Buy 6.15% -2.44%
OMI Owens & Minor, Inc. Buy 6.93% 14.73%
BRKR Bruker Corporation Buy 6.23% 4.56%
NUTX Nutex Health Inc. Buy 5.79% -8.2%
CUTR Cutera, Inc. Buy 5.45% -8.97%
NVAX Novavax, Inc. Buy 9.51% 40%
MYGN Myriad Genetics, Inc. Buy 6.77% -0.38%
INGN Inogen, Inc. Buy 7.08% -7.98%
RCM R1 RCM Inc. Buy 7.56% 30.53%
CARA Cara Therapeutics, Inc. Buy 8.53% 47.35%
TVTX Travere Therapeutics, Inc. Sell -3.11% -0.61%
NVTA Invitae Corporation Sell -0.39% 87.43%
CTLT Catalent, Inc. Sell -4.03% -3.01%
MCRB Seres Therapeutics, Inc. Sell -4.37% -11.76%
HAE Haemonetics Corporation Sell -3.71% -0.11%
GKOS Glaukos Corporation Sell -3.07% 3.31%
SAGE Sage Therapeutics, Inc. Sell -4.36% 2.41%
TDOC Teladoc Health, Inc. Sell -3.17% 3.07%
The percentage of cash held in the portfolio is: 16.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
VKTX Sell All 194.39%
Assets Rebalanced
None
2024-02-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 7.26% 3.2%
ATRI Atrion Corporation Buy 6.68% 0.57%
RGNX REGENXBIO Inc. Buy 6.74% 19.49%
VKTX Viking Therapeutics, Inc. Buy 7.58% 29.53%
CERS Cerus Corporation Buy 7.17% -3.91%
FATE Fate Therapeutics, Inc. Buy 8.05% 10.65%
CHRS Coherus BioSciences, Inc. Buy 7.25% -1.53%
ACRS Aclaris Therapeutics, Inc. Buy 7.13% -3.25%
OMI Owens & Minor, Inc. Buy 7.81% 10.61%
BRKR Bruker Corporation Buy 7.36% 5.77%
NUTX Nutex Health Inc. Buy 7.12% -3.28%
CUTR Cutera, Inc. Buy 5.79% -17.24%
NVAX Novavax, Inc. Buy 9.77% 23.02%
MYGN Myriad Genetics, Inc. Buy 7.65% -3.69%
INGN Inogen, Inc. Buy 8.14% -9.46%
RCM R1 RCM Inc. Buy 6.73% -0.63%
CARA Cara Therapeutics, Inc. Buy 9.56% 41.28%
TVTX Travere Therapeutics, Inc. Sell -3.47% 3.87%
NVTA Invitae Corporation Sell -0.49% 86.53%
CTLT Catalent, Inc. Sell -4.75% -4.02%
MCRB Seres Therapeutics, Inc. Sell -4.75% -3.92%
HAE Haemonetics Corporation Sell -4.29% 0.93%
GKOS Glaukos Corporation Sell -3.55% 4.27%
SAGE Sage Therapeutics, Inc. Sell -4.94% 5.41%
TDOC Teladoc Health, Inc. Sell -3.54% 7.29%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
INGN Buy 0.95%
2024-02-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 7.72% 7.47%
ATRI Atrion Corporation Buy 6.62% -2.34%
RGNX REGENXBIO Inc. Buy 7.18% 24.71%
VKTX Viking Therapeutics, Inc. Buy 7.38% 23.43%
CERS Cerus Corporation Buy 7.35% -3.48%
ACRS Aclaris Therapeutics, Inc. Buy 7.4% -1.63%
FATE Fate Therapeutics, Inc. Buy 8.12% 9.38%
CHRS Coherus BioSciences, Inc. Buy 7.09% -5.73%
OMI Owens & Minor, Inc. Buy 7.75% 7.46%
BRKR Bruker Corporation Buy 7.44% 4.61%
NUTX Nutex Health Inc. Buy 7.28% -3.28%
CUTR Cutera, Inc. Buy 6.5% -8.97%
NVAX Novavax, Inc. Buy 9.2% 13.49%
MYGN Myriad Genetics, Inc. Buy 7.94% -2.08%
INGN Inogen, Inc. Buy 7.49% -7.68%
RCM R1 RCM Inc. Buy 6.9% -0.27%
CARA Cara Therapeutics, Inc. Buy 8.6% 24.45%
NVTA Invitae Corporation Sell -0.56% 84.85%
TVTX Travere Therapeutics, Inc. Sell -3.51% 4.84%
CTLT Catalent, Inc. Sell -4.82% -3.36%
MCRB Seres Therapeutics, Inc. Sell -5.03% -7.84%
HAE Haemonetics Corporation Sell -4.46% -0.94%
GKOS Glaukos Corporation Sell -3.71% 2.25%
SAGE Sage Therapeutics, Inc. Sell -5.1% 4.38%
TDOC Teladoc Health, Inc. Sell -3.79% 2.75%
The percentage of cash held in the portfolio is: 3.01%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
FATE Buy 0.2%
2024-02-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 7.91% 6.29%
ATRI Atrion Corporation Buy 7.31% 4.18%
RGNX REGENXBIO Inc. Buy 7.53% 26.29%
CERS Cerus Corporation Buy 7.68% -2.61%
VKTX Viking Therapeutics, Inc. Buy 7.53% 21.77%
ACRS Aclaris Therapeutics, Inc. Buy 7.6% -2.44%
CHRS Coherus BioSciences, Inc. Buy 7.37% -5.34%
FATE Fate Therapeutics, Inc. Buy 7.53% 8.59%
OMI Owens & Minor, Inc. Buy 7.53% 0.93%
NUTX Nutex Health Inc. Buy 7.53% -3.28%
CUTR Cutera, Inc. Buy 6.91% -6.55%
BRKR Bruker Corporation Buy 7.53% 2.34%
MYGN Myriad Genetics, Inc. Buy 8.15% -2.88%
NVAX Novavax, Inc. Buy 7.77% -7.44%
INGN Inogen, Inc. Buy 7.76% -7.49%
RCM R1 RCM Inc. Buy 6.84% -4.39%
CARA Cara Therapeutics, Inc. Buy 7.53% 5.3%
NVTA Invitae Corporation Sell -0.64% 83.16%
TVTX Travere Therapeutics, Inc. Sell -3.64% 4.6%
CTLT Catalent, Inc. Sell -4.98% -3.08%
MCRB Seres Therapeutics, Inc. Sell -4.97% -2.94%
HAE Haemonetics Corporation Sell -4.52% 1.25%
GKOS Glaukos Corporation Sell -3.89% 0.83%
SAGE Sage Therapeutics, Inc. Sell -5.26% 4.6%
TDOC Teladoc Health, Inc. Sell -4.04% 0%
The percentage of cash held in the portfolio is: 3.94%
New Assets Added
  • TDOC
Assets Removed
Asset Action Perf %
EBS Buy All -64.24%
Assets Rebalanced
Asset Action Weight
RCM Sell -1.18%
CUTR Sell -1.48%
FATE Sell -0.93%
NUTX Sell -1.15%
BRKR Sell -1.65%
VKTX Sell -2.07%
RGNX Sell -2.35%
NTLA Buy 0.82%
CARA Buy 1.04%
OMI Buy 4.62%
2024-02-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 6.48% 7.35%
ATRI Atrion Corporation Buy 6.87% 2.22%
RGNX REGENXBIO Inc. Buy 9.53% 27.25%
VKTX Viking Therapeutics, Inc. Buy 9.34% 23.71%
CERS Cerus Corporation Buy 7.58% 0.43%
FATE Fate Therapeutics, Inc. Buy 8.37% 12.24%
CHRS Coherus BioSciences, Inc. Buy 7.37% -1.15%
ACRS Aclaris Therapeutics, Inc. Buy 7.33% -1.63%
OMI Owens & Minor, Inc. Buy 2.75% -0.23%
NUTX Nutex Health Inc. Buy 8.1% -5.74%
BRKR Bruker Corporation Buy 8.7% 1.31%
CUTR Cutera, Inc. Buy 8.68% 1.03%
RCM R1 RCM Inc. Buy 7.75% -3.58%
INGN Inogen, Inc. Buy 7.51% -6.5%
NVAX Novavax, Inc. Buy 7.72% -3.95%
MYGN Myriad Genetics, Inc. Buy 8.01% -0.38%
CARA Cara Therapeutics, Inc. Buy 5.9% 0%
EBS Emergent BioSolutions Inc. Sell -3.35% 7.88%
TVTX Travere Therapeutics, Inc. Sell -3.66% -0.24%
NVTA Invitae Corporation Sell -0.69% 81.14%
MCRB Seres Therapeutics, Inc. Sell -4.72% -1.96%
CTLT Catalent, Inc. Sell -4.75% -2.62%
HAE Haemonetics Corporation Sell -4.22% 3.73%
GKOS Glaukos Corporation Sell -3.7% 1.54%
SAGE Sage Therapeutics, Inc. Sell -5.03% 4.73%
The percentage of cash held in the portfolio is: 2.12%
New Assets Added
  • CARA
Assets Removed
Asset Action Perf %
MRSN Sell All -14.18%
Assets Rebalanced
None
2024-02-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 6.48% 9.69%
ATRI Atrion Corporation Buy 6.65% 1.11%
RGNX REGENXBIO Inc. Buy 9.47% 29.24%
MRSN Mersana Therapeutics, Inc. Buy 6.63% -10.17%
VKTX Viking Therapeutics, Inc. Buy 9.25% 25.3%
CERS Cerus Corporation Buy 7.58% 2.61%
FATE Fate Therapeutics, Inc. Buy 8.77% 20.19%
CHRS Coherus BioSciences, Inc. Buy 7.68% 5.34%
ACRS Aclaris Therapeutics, Inc. Buy 7.06% -3.25%
OMI Owens & Minor, Inc. Buy 2.65% -1.76%
NUTX Nutex Health Inc. Buy 8.41% 0%
BRKR Bruker Corporation Buy 8.59% 2.21%
CUTR Cutera, Inc. Buy 8.49% 1.03%
RCM R1 RCM Inc. Buy 7.65% -2.69%
INGN Inogen, Inc. Buy 7.77% -1.18%
NVAX Novavax, Inc. Buy 7.61% -3.26%
MYGN Myriad Genetics, Inc. Buy 7.75% -1.44%
EBS Emergent BioSolutions Inc. Sell -3.37% 5.45%
TVTX Travere Therapeutics, Inc. Sell -3.55% 0.73%
NVTA Invitae Corporation Sell -0.78% 78.11%
MCRB Seres Therapeutics, Inc. Sell -4.66% -2.94%
CTLT Catalent, Inc. Sell -4.66% -2.9%
HAE Haemonetics Corporation Sell -4.18% 2.48%
GKOS Glaukos Corporation Sell -3.64% 1%
SAGE Sage Therapeutics, Inc. Sell -5.17% 0%
The percentage of cash held in the portfolio is: 1.51%
New Assets Added
  • SAGE
Assets Removed
Asset Action Perf %
SGMO Buy All -31.43%
Assets Rebalanced
None
2024-02-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 6.66% 12.57%
ATRI Atrion Corporation Buy 6.68% 1.57%
RGNX REGENXBIO Inc. Buy 9.28% 26.63%
MRSN Mersana Therapeutics, Inc. Buy 6.71% -9.22%
VKTX Viking Therapeutics, Inc. Buy 8.14% 10.25%
CERS Cerus Corporation Buy 7.68% 3.91%
FATE Fate Therapeutics, Inc. Buy 8.21% 12.56%
CHRS Coherus BioSciences, Inc. Buy 7.94% 8.78%
ACRS Aclaris Therapeutics, Inc. Buy 7.3% 0%
OMI Owens & Minor, Inc. Buy 2.69% -0.46%
NUTX Nutex Health Inc. Buy 8.34% -0.82%
BRKR Bruker Corporation Buy 8.41% 0.06%
CUTR Cutera, Inc. Buy 8.5% 1.03%
RCM R1 RCM Inc. Buy 7.87% 0%
INGN Inogen, Inc. Buy 7.87% 0%
NVAX Novavax, Inc. Buy 7.87% 0%
MYGN Myriad Genetics, Inc. Buy 7.87% 0%
EBS Emergent BioSolutions Inc. Sell -3.67% -3.03%
TVTX Travere Therapeutics, Inc. Sell -3.78% -5.81%
NVTA Invitae Corporation Sell -0.73% 79.46%
MCRB Seres Therapeutics, Inc. Sell -4.97% -9.8%
CTLT Catalent, Inc. Sell -4.6% -1.66%
HAE Haemonetics Corporation Sell -4.16% 3.13%
GKOS Glaukos Corporation Sell -3.78% -2.71%
SGMO Sangamo Therapeutics, Inc. Sell -4.31% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SGMO
  • RCM
  • INGN
  • NVAX
  • MYGN
Assets Removed
Asset Action Perf %
SMTI Buy All -13.95%
AGEN Sell All -7.14%
Assets Rebalanced
None
2024-02-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 6.56% 11.82%
ATRI Atrion Corporation Buy 6.3% -3.57%
AGEN Agenus Inc. Buy 8.66% 32.56%
RGNX REGENXBIO Inc. Buy 8.39% 15.24%
MRSN Mersana Therapeutics, Inc. Buy 6.57% -10.4%
VKTX Viking Therapeutics, Inc. Buy 8.18% 11.56%
CERS Cerus Corporation Buy 7.43% 1.3%
FATE Fate Therapeutics, Inc. Buy 7.48% 3.18%
CHRS Coherus BioSciences, Inc. Buy 7.52% 3.82%
ACRS Aclaris Therapeutics, Inc. Buy 7.19% -0.81%
OMI Owens & Minor, Inc. Buy 2.67% -0.42%
NUTX Nutex Health Inc. Buy 8.35% 0%
BRKR Bruker Corporation Buy 8.35% 0%
CUTR Cutera, Inc. Buy 8.35% 0%
EBS Emergent BioSolutions Inc. Sell -3.63% -2.42%
TVTX Travere Therapeutics, Inc. Sell -3.54% 0.12%
NVTA Invitae Corporation Sell -0.76% 78.68%
MCRB Seres Therapeutics, Inc. Sell -4.85% -7.84%
CTLT Catalent, Inc. Sell -4.53% -0.78%
HAE Haemonetics Corporation Sell -4.09% 3.99%
SMTI Sanara MedTech Inc. Sell -3.97% -8.63%
GKOS Glaukos Corporation Sell -3.7% -1.24%
The percentage of cash held in the portfolio is: 27.05%
New Assets Added
  • NUTX
  • BRKR
  • CUTR
Assets Removed
Asset Action Perf %
LXRX Sell All 55.87%
Assets Rebalanced
None
2024-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 8.47% 37.56%
NTLA Intellia Therapeutics, Inc. Buy 6.44% 4.59%
ATRI Atrion Corporation Buy 6.71% -2.04%
AGEN Agenus Inc. Buy 7.44% 8.57%
RGNX REGENXBIO Inc. Buy 8.4% 10.09%
MRSN Mersana Therapeutics, Inc. Buy 6.97% -9.46%
VKTX Viking Therapeutics, Inc. Buy 8.15% 5.92%
CERS Cerus Corporation Buy 7.26% -5.65%
FATE Fate Therapeutics, Inc. Buy 7.72% 1.59%
CHRS Coherus BioSciences, Inc. Buy 7.43% -2.29%
ACRS Aclaris Therapeutics, Inc. Buy 7.23% -4.88%
OMI Owens & Minor, Inc. Buy 2.75% -2.32%
EBS Emergent BioSolutions Inc. Sell -3.58% 3.64%
TVTX Travere Therapeutics, Inc. Sell -3.6% 3.27%
NVTA Invitae Corporation Sell -1.25% 66.33%
MCRB Seres Therapeutics, Inc. Sell -4.9% -3.92%
CTLT Catalent, Inc. Sell -4.69% 0.46%
HAE Haemonetics Corporation Sell -4.32% 3.37%
SMTI Sanara MedTech Inc. Sell -3.83% 0%
GKOS Glaukos Corporation Sell -3.83% 0%
The percentage of cash held in the portfolio is: 45.04%
New Assets Added
  • SMTI
  • GKOS
Assets Removed
Asset Action Perf %
ARCT Sell All 2.7%
DCPH Sell All -7.82%
SAVA Sell All -6.26%
SMTI Sell All -9.09%
CLDX Sell All -6.72%
Assets Rebalanced
None
2024-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 7.94% 37.09%
NTLA Intellia Therapeutics, Inc. Buy 6.78% 17.08%
ATRI Atrion Corporation Buy 7.2% 11.82%
ARCT Arcturus Therapeutics Holdings Inc. Buy 7.1% 10.25%
AGEN Agenus Inc. Buy 7.45% 15.71%
SMTI Sanara MedTech Inc. Buy 7.04% -1.84%
RGNX REGENXBIO Inc. Buy 8.55% 19.15%
CLDX Celldex Therapeutics, Inc. Buy 7.13% -0.58%
SAVA Cassava Sciences, Inc. Buy 7.04% -1.93%
MRSN Mersana Therapeutics, Inc. Buy 6.72% -7.09%
VKTX Viking Therapeutics, Inc. Buy 7.94% 9.81%
CERS Cerus Corporation Buy 7.45% 3.04%
FATE Fate Therapeutics, Inc. Buy 7.79% 9.06%
CHRS Coherus BioSciences, Inc. Buy 7.69% 7.63%
ACRS Aclaris Therapeutics, Inc. Buy 7.15% 0%
DCPH Deciphera Pharmaceuticals, Inc. Buy 7.08% -0.95%
OMI Owens & Minor, Inc. Buy 2.65% 0%
EBS Emergent BioSolutions Inc. Sell -3.81% -9.09%
TVTX Travere Therapeutics, Inc. Sell -3.75% -7.26%
NVTA Invitae Corporation Sell -1.45% 58.47%
MCRB Seres Therapeutics, Inc. Sell -5% -12.75%
CTLT Catalent, Inc. Sell -4.47% -0.87%
HAE Haemonetics Corporation Sell -4.23% -0.77%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OMI
Assets Removed
Asset Action Perf %
CUTR Buy All -27.2%
Assets Rebalanced
None
2024-02-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.66% 12.21%
NTLA Intellia Therapeutics, Inc. Buy 6.62% 11.63%
ATRI Atrion Corporation Buy 7.19% 8.91%
ARCT Arcturus Therapeutics Holdings Inc. Buy 6.93% 5.01%
AGEN Agenus Inc. Buy 7.07% 7.14%
SMTI Sanara MedTech Inc. Buy 7.52% 2.2%
RGNX REGENXBIO Inc. Buy 8.18% 11.26%
CLDX Celldex Therapeutics, Inc. Buy 7.4% 0.61%
SAVA Cassava Sciences, Inc. Buy 7.26% -1.34%
MRSN Mersana Therapeutics, Inc. Buy 6.8% -8.27%
VKTX Viking Therapeutics, Inc. Buy 7.85% 5.85%
CERS Cerus Corporation Buy 7.61% 2.61%
FATE Fate Therapeutics, Inc. Buy 7.32% 0%
CHRS Coherus BioSciences, Inc. Buy 7.32% 0%
ACRS Aclaris Therapeutics, Inc. Buy 7.32% 0%
DCPH Deciphera Pharmaceuticals, Inc. Buy 7.32% 0%
EBS Emergent BioSolutions Inc. Sell -3.43% 4.24%
CUTR Cutera, Inc. Sell -3.93% -9.62%
TVTX Travere Therapeutics, Inc. Sell -3.68% -2.66%
NVTA Invitae Corporation Sell -0.8% 77.55%
MCRB Seres Therapeutics, Inc. Sell -4.99% -9.8%
CTLT Catalent, Inc. Sell -4.56% -0.37%
HAE Haemonetics Corporation Sell -4.31% 0%
The percentage of cash held in the portfolio is: 9.32%
New Assets Added
  • HAE
  • FATE
  • CHRS
  • ACRS
  • DCPH
Assets Removed
Asset Action Perf %
CARA Buy All -8.85%
Assets Rebalanced
None
2024-02-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.45% 7.98%
NTLA Intellia Therapeutics, Inc. Buy 6.48% 8.62%
ATRI Atrion Corporation Buy 7.02% 5.75%
ARCT Arcturus Therapeutics Holdings Inc. Buy 6.67% 0.42%
AGEN Agenus Inc. Buy 6.64% 0%
SMTI Sanara MedTech Inc. Buy 7.7% 4.06%
RGNX REGENXBIO Inc. Buy 8.27% 11.81%
CLDX Celldex Therapeutics, Inc. Buy 7.34% -0.77%
SAVA Cassava Sciences, Inc. Buy 7.36% -0.59%
MRSN Mersana Therapeutics, Inc. Buy 7.46% 0%
VKTX Viking Therapeutics, Inc. Buy 7.46% 0%
CERS Cerus Corporation Buy 7.46% 0%
EBS Emergent BioSolutions Inc. Sell -3.66% -1.82%
CUTR Cutera, Inc. Sell -4% -10.88%
TVTX Travere Therapeutics, Inc. Sell -3.63% -0.48%
NVTA Invitae Corporation Sell -0.73% 79.8%
MCRB Seres Therapeutics, Inc. Sell -4.64% -1.47%
CTLT Catalent, Inc. Sell -4.57% -0.09%
CARA Cara Therapeutics, Inc. Sell -4.38% 0%
The percentage of cash held in the portfolio is: 39.3%
New Assets Added
  • CARA
  • MRSN
  • VKTX
  • CERS
Assets Removed
Asset Action Perf %
PAHC Buy All -7.81%
Assets Rebalanced
None
2024-02-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.14% 0.94%
NTLA Intellia Therapeutics, Inc. Buy 6.27% 3.08%
ATRI Atrion Corporation Buy 7.15% 5.59%
ARCT Arcturus Therapeutics Holdings Inc. Buy 6.69% -1.19%
AGEN Agenus Inc. Buy 6.58% -2.86%
SMTI Sanara MedTech Inc. Buy 7.54% 0%
RGNX REGENXBIO Inc. Buy 7.54% 0%
CLDX Celldex Therapeutics, Inc. Buy 7.54% 0%
SAVA Cassava Sciences, Inc. Buy 7.54% 0%
EBS Emergent BioSolutions Inc. Sell -3.33% 9.09%
PAHC Phibro Animal Health Corporation Sell -3.68% -0.38%
CUTR Cutera, Inc. Sell -4.29% -16.74%
TVTX Travere Therapeutics, Inc. Sell -3.69% -0.24%
NVTA Invitae Corporation Sell -1.03% 71.94%
MCRB Seres Therapeutics, Inc. Sell -4.66% 0%
CTLT Catalent, Inc. Sell -4.66% 0%
The percentage of cash held in the portfolio is: 62.34%
New Assets Added
  • MCRB
  • CTLT
  • SMTI
  • RGNX
  • CLDX
  • SAVA
Assets Removed
None
Assets Rebalanced
None
2024-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.49% 3.76%
NTLA Intellia Therapeutics, Inc. Buy 6.58% 5.06%
ATRI Atrion Corporation Buy 6.97% 0%
ARCT Arcturus Therapeutics Holdings Inc. Buy 6.97% 0%
AGEN Agenus Inc. Buy 6.97% 0%
EBS Emergent BioSolutions Inc. Sell -3.57% 5.45%
PAHC Phibro Animal Health Corporation Sell -3.84% -1.79%
CUTR Cutera, Inc. Sell -4.4% -16.32%
TVTX Travere Therapeutics, Inc. Sell -3.97% -4.96%
NVTA Invitae Corporation Sell -3.78% 0.11%
The percentage of cash held in the portfolio is: 85.59%
New Assets Added
  • ATRI
  • ARCT
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.02% -3.76%
NTLA Intellia Therapeutics, Inc. Buy 6.15% -1.78%
EBS Emergent BioSolutions Inc. Sell -3.5% 7.27%
PAHC Phibro Animal Health Corporation Sell -3.8% -0.85%
CUTR Cutera, Inc. Sell -3.78% 0%
TVTX Travere Therapeutics, Inc. Sell -3.78% 0%
NVTA Invitae Corporation Sell -3.78% 0%
The percentage of cash held in the portfolio is: 106.48%
New Assets Added
  • CUTR
  • TVTX
  • NVTA
Assets Removed
Asset Action Perf %
PTGX Sell All -8.8%
Assets Rebalanced
None
2024-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 5.58% -7.12%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.24% 0%
NTLA Intellia Therapeutics, Inc. Buy 6.24% 0%
EBS Emergent BioSolutions Inc. Sell -3.7% 1.82%
PAHC Phibro Animal Health Corporation Sell -3.76% 0%
The percentage of cash held in the portfolio is: 89.39%
New Assets Added
  • PAHC
  • LXRX
  • NTLA
Assets Removed
None
Assets Rebalanced
None
2024-02-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 5.99% 0%
EBS Emergent BioSolutions Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 97.76%
New Assets Added
  • EBS
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2023-12-20 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 7.75%
Assets Rebalanced
None
2023-12-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
STAA STAAR Surgical Company Sell -3.38% 4.08%
The percentage of cash held in the portfolio is: 103.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
HCSG Sell All -1.67%
MRSN Sell All 33.12%
Assets Rebalanced
None
2023-12-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 5.16% -0.59%
MRSN Mersana Therapeutics, Inc. Buy 14.33% 29.87%
STAA STAAR Surgical Company Sell -3.59% -1.38%
The percentage of cash held in the portfolio is: 84.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All 6.02%
SGRY Sell All 17.23%
AMEH Sell All 8.26%
KIDS Sell All 7.32%
QTRX Sell All 11.25%
MCRB Sell All -12.9%
Assets Rebalanced
None
2023-12-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 5.68% 3.28%
SGRY Surgery Partners, Inc. Buy 6.25% 13.65%
AMEH Apollo Medical Holdings, Inc. Buy 5.71% 3.72%
KIDS OrthoPediatrics Corp. Buy 5.71% 3.74%
QTRX Quanterix Corporation Buy 6.08% 10.59%
MCRB Seres Therapeutics, Inc. Buy 4.66% -15.32%
HCSG Healthcare Services Group, Inc. Buy 5.23% 0.29%
MRSN Mersana Therapeutics, Inc. Buy 14.75% 33.12%
STAA STAAR Surgical Company Sell -3.44% 3.39%
The percentage of cash held in the portfolio is: 49.37%
New Assets Added
None
Assets Removed
Asset Action Perf %
CBAY Sell All 26.67%
SENS Sell All 13.51%
Assets Rebalanced
None
2023-12-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
CBAY CymaBay Therapeutics, Inc. Buy 8.02% 23.77%
SENS Senseonics Holdings, Inc. Buy 7.36% 13.69%
NVCR NovoCure Limited Buy 5.47% -2.34%
SGRY Surgery Partners, Inc. Buy 5.94% 5.96%
AMEH Apollo Medical Holdings, Inc. Buy 5.48% -2.17%
KIDS OrthoPediatrics Corp. Buy 5.72% 2.07%
QTRX Quanterix Corporation Buy 5.7% 1.68%
MCRB Seres Therapeutics, Inc. Buy 4.93% -12.1%
HCSG Healthcare Services Group, Inc. Buy 5.11% -3.73%
MRSN Mersana Therapeutics, Inc. Buy 15.02% 33.12%
STAA STAAR Surgical Company Sell -3.47% 4.11%
The percentage of cash held in the portfolio is: 34.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMRX Buy All -15.79%
Assets Rebalanced
None
2023-12-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CBAY CymaBay Therapeutics, Inc. Buy 8.28% 29.05%
SENS Senseonics Holdings, Inc. Buy 7.26% 13.15%
NVCR NovoCure Limited Buy 5.58% 0.62%
SGRY Surgery Partners, Inc. Buy 5.97% 7.62%
AMEH Apollo Medical Holdings, Inc. Buy 5.41% -2.46%
KIDS OrthoPediatrics Corp. Buy 5.65% 1.87%
QTRX Quanterix Corporation Buy 5.57% 0.4%
MCRB Seres Therapeutics, Inc. Buy 4.92% -11.29%
HCSG Healthcare Services Group, Inc. Buy 5.12% -2.65%
MRSN Mersana Therapeutics, Inc. Buy 14.8% 32.47%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.48% -7.32%
STAA STAAR Surgical Company Sell -3.23% 10.08%
The percentage of cash held in the portfolio is: 38.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
BMRN Sell All 11.05%
Assets Rebalanced
None
2023-12-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 9.22% 10.14%
CBAY CymaBay Therapeutics, Inc. Buy 7.89% 23.65%
SENS Senseonics Holdings, Inc. Buy 7.1% 11.17%
NVCR NovoCure Limited Buy 5.55% 0.55%
SGRY Surgery Partners, Inc. Buy 6.02% 8.95%
AMEH Apollo Medical Holdings, Inc. Buy 5.42% -1.85%
KIDS OrthoPediatrics Corp. Buy 5.4% -2.14%
QTRX Quanterix Corporation Buy 5.65% 2.38%
MCRB Seres Therapeutics, Inc. Buy 4.81% -12.9%
HCSG Healthcare Services Group, Inc. Buy 5.03% -3.83%
MRSN Mersana Therapeutics, Inc. Buy 15.74% 41.56%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.36% -4.12%
STAA STAAR Surgical Company Sell -3.14% 12.14%
The percentage of cash held in the portfolio is: 28.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
MNKD Buy All 2.45%
NVAX Buy All 19.01%
VCEL Sell All -8.52%
Assets Rebalanced
None
2023-12-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 9.17% 9.5%
CBAY CymaBay Therapeutics, Inc. Buy 7.73% 21.04%
SENS Senseonics Holdings, Inc. Buy 7.36% 15.32%
NVCR NovoCure Limited Buy 5.51% -0.23%
SGRY Surgery Partners, Inc. Buy 6.19% 12.06%
AMEH Apollo Medical Holdings, Inc. Buy 5.45% -1.35%
KIDS OrthoPediatrics Corp. Buy 5.43% -1.71%
QTRX Quanterix Corporation Buy 5.75% 4.15%
MCRB Seres Therapeutics, Inc. Buy 4.72% -14.52%
VCEL Vericel Corporation Buy 5.27% -4.52%
HCSG Healthcare Services Group, Inc. Buy 5.1% -2.45%
MRSN Mersana Therapeutics, Inc. Buy 15.39% 38.31%
MNKD MannKind Corporation Sell -3.4% -0.82%
NVAX Novavax, Inc. Sell -2.73% 18.87%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.41% -5.72%
STAA STAAR Surgical Company Sell -3.16% 11.57%
The percentage of cash held in the portfolio is: 29.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
VKTX Sell All 55.42%
Assets Rebalanced
None
2023-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 9.27% 10.42%
CBAY CymaBay Therapeutics, Inc. Buy 7.73% 20.69%
SENS Senseonics Holdings, Inc. Buy 7.6% 18.74%
NVCR NovoCure Limited Buy 5.62% 1.48%
SGRY Surgery Partners, Inc. Buy 6.52% 17.66%
AMEH Apollo Medical Holdings, Inc. Buy 5.66% 2.23%
KIDS OrthoPediatrics Corp. Buy 5.58% 0.67%
QTRX Quanterix Corporation Buy 6.02% 8.74%
VKTX Viking Therapeutics, Inc. Buy 7.48% 35%
MCRB Seres Therapeutics, Inc. Buy 5.09% -8.06%
VCEL Vericel Corporation Buy 5.43% -1.99%
HCSG Healthcare Services Group, Inc. Buy 5.19% -0.98%
MRSN Mersana Therapeutics, Inc. Buy 14.78% 32.47%
MNKD MannKind Corporation Sell -3.44% -1.9%
NVAX Novavax, Inc. Sell -2.82% 16.55%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.49% -7.78%
STAA STAAR Surgical Company Sell -3.32% 7.29%
The percentage of cash held in the portfolio is: 21.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMN Buy All -8.62%
Assets Rebalanced
None
2023-12-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 9.36% 8.11%
CBAY CymaBay Therapeutics, Inc. Buy 7.71% 16.83%
SENS Senseonics Holdings, Inc. Buy 7.6% 15.14%
NVCR NovoCure Limited Buy 5.58% -2.34%
SGRY Surgery Partners, Inc. Buy 6.44% 12.82%
AMEH Apollo Medical Holdings, Inc. Buy 5.82% 1.99%
KIDS OrthoPediatrics Corp. Buy 5.97% 4.61%
QTRX Quanterix Corporation Buy 6.4% 12%
VKTX Viking Therapeutics, Inc. Buy 6.65% 16.47%
MCRB Seres Therapeutics, Inc. Buy 4.93% -13.71%
VCEL Vericel Corporation Buy 5.54% -3.07%
HCSG Healthcare Services Group, Inc. Buy 5.31% -1.86%
MRSN Mersana Therapeutics, Inc. Buy 14.19% 23.38%
AMN AMN Healthcare Services, Inc. Sell -3.36% -3.07%
MNKD MannKind Corporation Sell -3.57% -2.45%
NVAX Novavax, Inc. Sell -2.82% 19.16%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.56% -6.64%
STAA STAAR Surgical Company Sell -3.5% 5.28%
The percentage of cash held in the portfolio is: 25.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGIO Buy All -8.33%
EW Sell All 7.1%
ISRG Sell All 13.43%
RMD Sell All 6.36%
THC Sell All 31.6%
Assets Rebalanced
None
2023-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 7.6% 4.81%
ISRG Intuitive Surgical, Inc. Buy 6.85% 9.86%
RMD ResMed Inc. Buy 6.19% -0.77%
THC Tenet Healthcare Corporation Buy 7.37% 18.12%
BMRN BioMarin Pharmaceutical Inc. Buy 9.43% 2.37%
CBAY CymaBay Therapeutics, Inc. Buy 7.64% 8.83%
SENS Senseonics Holdings, Inc. Buy 7.44% 5.95%
NVCR NovoCure Limited Buy 5.87% -3.36%
SGRY Surgery Partners, Inc. Buy 6.49% 6.83%
AMEH Apollo Medical Holdings, Inc. Buy 6.25% 2.96%
KIDS OrthoPediatrics Corp. Buy 6.34% 4.35%
QTRX Quanterix Corporation Buy 6.02% -0.93%
VKTX Viking Therapeutics, Inc. Buy 6.13% 0.9%
MCRB Seres Therapeutics, Inc. Buy 6.96% 14.52%
VCEL Vericel Corporation Buy 6.05% -0.46%
HCSG Healthcare Services Group, Inc. Buy 5.68% -1.18%
MRSN Mersana Therapeutics, Inc. Buy 12.31% 0.65%
AMN AMN Healthcare Services, Inc. Sell -3.44% 0.76%
MNKD MannKind Corporation Sell -3.83% -3.26%
NVAX Novavax, Inc. Sell -3.08% 16.84%
AGIO Agios Pharmaceuticals, Inc. Sell -4.19% -5.3%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.68% -3.66%
STAA STAAR Surgical Company Sell -3.93% 0%
The percentage of cash held in the portfolio is: 1.53%
New Assets Added
  • STAA
Assets Removed
Asset Action Perf %
OMI Buy All -8.89%
Assets Rebalanced
None
2023-11-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 7.89% 5.7%
ISRG Intuitive Surgical, Inc. Buy 7.02% 9.38%
RMD ResMed Inc. Buy 6.37% -0.8%
THC Tenet Healthcare Corporation Buy 6.91% 7.75%
BMRN BioMarin Pharmaceutical Inc. Buy 9.66% 2.01%
CBAY CymaBay Therapeutics, Inc. Buy 7.79% 7.82%
SENS Senseonics Holdings, Inc. Buy 7.77% 7.57%
NVCR NovoCure Limited Buy 5.77% -7.58%
SGRY Surgery Partners, Inc. Buy 6.37% 2.02%
AMEH Apollo Medical Holdings, Inc. Buy 6.39% 2.26%
KIDS OrthoPediatrics Corp. Buy 6.48% 3.68%
QTRX Quanterix Corporation Buy 6.04% -3.35%
VKTX Viking Therapeutics, Inc. Buy 5.89% -5.73%
MCRB Seres Therapeutics, Inc. Buy 5.84% -6.45%
VCEL Vericel Corporation Buy 6.05% -3.18%
HCSG Healthcare Services Group, Inc. Buy 5.88% -0.69%
MRSN Mersana Therapeutics, Inc. Buy 12.58% 0%
AMN AMN Healthcare Services, Inc. Sell -3.5% 1.91%
MNKD MannKind Corporation Sell -3.73% 2.17%
NVAX Novavax, Inc. Sell -3.22% 15.38%
OMI Owens & Minor, Inc. Sell -4.28% -4.53%
AGIO Agios Pharmaceuticals, Inc. Sell -4.31% -5.2%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.65% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMRX
  • MRSN
Assets Removed
Asset Action Perf %
AMRX Sell All 3.8%
Assets Rebalanced
None
2023-11-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 7.78% 4.98%
ISRG Intuitive Surgical, Inc. Buy 6.72% 5.52%
RMD ResMed Inc. Buy 6.46% 1.37%
THC Tenet Healthcare Corporation Buy 6.93% 8.69%
AMRX Amneal Pharmaceuticals, Inc. Buy 9.1% 6.65%
BMRN BioMarin Pharmaceutical Inc. Buy 9.58% 1.84%
CBAY CymaBay Therapeutics, Inc. Buy 7.65% 6.7%
SENS Senseonics Holdings, Inc. Buy 7.83% 9.19%
NVCR NovoCure Limited Buy 6.15% -0.94%
SGRY Surgery Partners, Inc. Buy 6.39% 2.98%
AMEH Apollo Medical Holdings, Inc. Buy 6.23% 0.41%
KIDS OrthoPediatrics Corp. Buy 6.39% 2.99%
QTRX Quanterix Corporation Buy 6.1% -1.72%
VKTX Viking Therapeutics, Inc. Buy 6.13% -1.25%
MCRB Seres Therapeutics, Inc. Buy 6% -3.23%
VCEL Vericel Corporation Buy 6.09% -1.9%
HCSG Healthcare Services Group, Inc. Buy 5.88% 0%
AMN AMN Healthcare Services, Inc. Sell -3.48% 1.61%
MNKD MannKind Corporation Sell -3.86% -1.9%
NVAX Novavax, Inc. Sell -3.41% 10.01%
OMI Owens & Minor, Inc. Sell -4.33% -6.5%
AGIO Agios Pharmaceuticals, Inc. Sell -4.33% -6.29%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
VTRS Buy All -4.58%
PODD Sell All 27.65%
Assets Rebalanced
None
2023-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.96% 27.25%
EW Edwards Lifesciences Corporation Buy 7.7% 3.07%
ISRG Intuitive Surgical, Inc. Buy 6.74% 4.94%
RMD ResMed Inc. Buy 6.3% -1.86%
THC Tenet Healthcare Corporation Buy 6.96% 8.34%
AMRX Amneal Pharmaceuticals, Inc. Buy 9.33% 8.55%
BMRN BioMarin Pharmaceutical Inc. Buy 9.41% -0.74%
CBAY CymaBay Therapeutics, Inc. Buy 7.37% 1.96%
SENS Senseonics Holdings, Inc. Buy 7.53% 4.22%
NVCR NovoCure Limited Buy 6.25% 0%
SGRY Surgery Partners, Inc. Buy 6.25% 0%
AMEH Apollo Medical Holdings, Inc. Buy 6.25% 0%
KIDS OrthoPediatrics Corp. Buy 6.25% 0%
QTRX Quanterix Corporation Buy 6.25% 0%
VKTX Viking Therapeutics, Inc. Buy 6.25% 0%
MCRB Seres Therapeutics, Inc. Buy 6.25% 0%
VCEL Vericel Corporation Buy 6.25% 0%
AMN AMN Healthcare Services, Inc. Sell -3.36% 5.76%
MNKD MannKind Corporation Sell -3.85% -1.09%
NVAX Novavax, Inc. Sell -3.45% 9.43%
OMI Owens & Minor, Inc. Sell -4.3% -4.94%
AGIO Agios Pharmaceuticals, Inc. Sell -4.32% -5.49%
VTRS Viatris Inc. Sell -3.99% -3.02%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
  • SGRY
  • AMEH
  • KIDS
  • QTRX
  • VKTX
  • MCRB
  • VCEL
Assets Removed
Asset Action Perf %
GKOS Buy All -5.96%
SGRY Buy All -17.8%
Assets Rebalanced
None
2023-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.55% 20.45%
EW Edwards Lifesciences Corporation Buy 7.65% 1.21%
ISRG Intuitive Surgical, Inc. Buy 6.61% 1.65%
RMD ResMed Inc. Buy 6.19% -4.78%
THC Tenet Healthcare Corporation Buy 6.61% 1.69%
AMRX Amneal Pharmaceuticals, Inc. Buy 8.85% 1.66%
BMRN BioMarin Pharmaceutical Inc. Buy 9.36% -2.46%
CBAY CymaBay Therapeutics, Inc. Buy 7.32% 0%
SENS Senseonics Holdings, Inc. Buy 7.32% 0%
AMN AMN Healthcare Services, Inc. Sell -3.13% 13.37%
MNKD MannKind Corporation Sell -3.71% 3.8%
NVAX Novavax, Inc. Sell -3.51% 9%
GKOS Glaukos Corporation Sell -4.48% -1.91%
SGRY Surgery Partners, Inc. Sell -2.85% -4.22%
OMI Owens & Minor, Inc. Sell -4.2% -1.22%
AGIO Agios Pharmaceuticals, Inc. Sell -4.19% -0.95%
VTRS Viatris Inc. Sell -3.93% 0%
The percentage of cash held in the portfolio is: 60.54%
New Assets Added
  • VTRS
  • CBAY
  • SENS
Assets Removed
None
Assets Rebalanced
None
2023-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.09% 14.12%
EW Edwards Lifesciences Corporation Buy 7.64% 0.6%
ISRG Intuitive Surgical, Inc. Buy 6.52% -0.14%
RMD ResMed Inc. Buy 6.25% -4.33%
THC Tenet Healthcare Corporation Buy 6.51% -0.32%
AMRX Amneal Pharmaceuticals, Inc. Buy 8.77% 0.24%
BMRN BioMarin Pharmaceutical Inc. Buy 9.47% -1.77%
AMN AMN Healthcare Services, Inc. Sell -3.27% 9.99%
MNKD MannKind Corporation Sell -3.62% 6.79%
NVAX Novavax, Inc. Sell -3.51% 9.43%
GKOS Glaukos Corporation Sell -4.29% 2.83%
SGRY Surgery Partners, Inc. Sell -2.8% -2.19%
OMI Owens & Minor, Inc. Sell -4.17% 0%
AGIO Agios Pharmaceuticals, Inc. Sell -4.17% 0%
The percentage of cash held in the portfolio is: 71.58%
New Assets Added
  • OMI
  • AGIO
Assets Removed
Asset Action Perf %
ABUS Buy All 3.8%
ANAB Buy All 22.99%
PCRX Buy All 3.13%
MODV Sell All 22.73%
Assets Rebalanced
None
2023-11-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 8.25% 21.26%
PODD Insulet Corporation Buy 9.07% 12.49%
EW Edwards Lifesciences Corporation Buy 7.79% 1.28%
ISRG Intuitive Surgical, Inc. Buy 6.48% -1.98%
RMD ResMed Inc. Buy 6.32% -4.45%
THC Tenet Healthcare Corporation Buy 6.45% -2.41%
AMRX Amneal Pharmaceuticals, Inc. Buy 8.73% -1.43%
BMRN BioMarin Pharmaceutical Inc. Buy 9.56% -2.07%
ABUS Arbutus Biopharma Corporation Sell -4.24% 2.17%
ANAB AnaptysBio, Inc. Sell -3.48% 19.71%
PCRX Pacira BioSciences, Inc. Sell -4.19% 3.3%
AMN AMN Healthcare Services, Inc. Sell -3.31% 9.8%
MNKD MannKind Corporation Sell -3.7% 5.71%
NVAX Novavax, Inc. Sell -3.82% 2.61%
GKOS Glaukos Corporation Sell -4.47% -0.18%
SGRY Surgery Partners, Inc. Sell -2.78% 0%
The percentage of cash held in the portfolio is: 67.36%
New Assets Added
  • SGRY
Assets Removed
Asset Action Perf %
VEEV Buy All 19.88%
EDIT Sell All 14.06%
INGN Sell All -6.24%
OMI Sell All 13.67%
SGRY Sell All 7.24%
VNDA Sell All -22.65%
ARDX Sell All -11.22%
Assets Rebalanced
None
2023-11-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 8.67% 33.08%
PODD Insulet Corporation Buy 8.8% 14.02%
EW Edwards Lifesciences Corporation Buy 7.64% 3.78%
EDIT Editas Medicine, Inc. Buy 8.97% 21.74%
VNDA Vanda Pharmaceuticals Inc. Buy 7.3% -0.92%
ISRG Intuitive Surgical, Inc. Buy 6.33% 0.01%
RMD ResMed Inc. Buy 6.28% -0.88%
THC Tenet Healthcare Corporation Buy 6.41% 1.22%
SGRY Surgery Partners, Inc. Buy 7.26% 14.61%
OMI Owens & Minor, Inc. Buy 7.55% 19.15%
INGN Inogen, Inc. Buy 6.43% 1.56%
ARDX Ardelyx, Inc. Buy 6.06% -4.24%
AMRX Amneal Pharmaceuticals, Inc. Buy 8.18% -3.56%
BMRN BioMarin Pharmaceutical Inc. Buy 9.35% 0.02%
ABUS Arbutus Biopharma Corporation Sell -4.22% -1.63%
ANAB AnaptysBio, Inc. Sell -3.46% 16.53%
PCRX Pacira BioSciences, Inc. Sell -4.22% -1.77%
VEEV Veeva Systems Inc. Sell -3.66% 6.64%
AMN AMN Healthcare Services, Inc. Sell -3.17% 9.93%
MNKD MannKind Corporation Sell -3.73% 0.82%
NVAX Novavax, Inc. Sell -3.71% 1.31%
GKOS Glaukos Corporation Sell -4.41% -3.02%
The percentage of cash held in the portfolio is: 25.35%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -4.54%
SMMT Sell All -6.41%
Assets Rebalanced
None
2023-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 8.46% 34.75%
PODD Insulet Corporation Buy 8.86% 19.1%
EW Edwards Lifesciences Corporation Buy 7.4% 4.23%
BCRX BioCryst Pharmaceuticals, Inc. Buy 7.52% 5.93%
EDIT Editas Medicine, Inc. Buy 9.22% 29.86%
SMMT Summit Therapeutics Inc. Buy 6.97% -1.79%
VNDA Vanda Pharmaceuticals Inc. Buy 7.2% 1.37%
ISRG Intuitive Surgical, Inc. Buy 6.12% 0.29%
RMD ResMed Inc. Buy 6.11% 0.11%
THC Tenet Healthcare Corporation Buy 6.29% 3.04%
SGRY Surgery Partners, Inc. Buy 7.23% 18.38%
OMI Owens & Minor, Inc. Buy 7.77% 27.27%
INGN Inogen, Inc. Buy 6.27% 2.73%
ARDX Ardelyx, Inc. Buy 6.2% 1.5%
AMRX Amneal Pharmaceuticals, Inc. Buy 8.37% 2.38%
BMRN BioMarin Pharmaceutical Inc. Buy 9.01% 0%
ABUS Arbutus Biopharma Corporation Sell -4.02% -0.54%
ANAB AnaptysBio, Inc. Sell -3.56% 11.04%
PCRX Pacira BioSciences, Inc. Sell -4.12% -2.99%
VEEV Veeva Systems Inc. Sell -3.52% 6.65%
AMN AMN Healthcare Services, Inc. Sell -3.18% 6.31%
MNKD MannKind Corporation Sell -3.74% -3.26%
NVAX Novavax, Inc. Sell -3.73% -2.9%
GKOS Glaukos Corporation Sell -4.12% 0%
The percentage of cash held in the portfolio is: 11.01%
New Assets Added
  • GKOS
  • BMRN
Assets Removed
Asset Action Perf %
VRTX Sell All 4.89%
CYTK Sell All 17.16%
Assets Rebalanced
None
2023-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 6.8% 6.97%
CYTK Cytokinetics, Incorporated Buy 7.15% 12.52%
MODV ModivCare Inc. Buy 8.74% 37.32%
PODD Insulet Corporation Buy 8.82% 16.93%
EW Edwards Lifesciences Corporation Buy 7.56% 5.12%
BCRX BioCryst Pharmaceuticals, Inc. Buy 7.45% 3.49%
EDIT Editas Medicine, Inc. Buy 8.67% 20.43%
SMMT Summit Therapeutics Inc. Buy 8.04% 11.79%
VNDA Vanda Pharmaceuticals Inc. Buy 7.34% 2.06%
ISRG Intuitive Surgical, Inc. Buy 6.17% -0.23%
RMD ResMed Inc. Buy 6.34% 2.52%
THC Tenet Healthcare Corporation Buy 6.26% 1.2%
SGRY Surgery Partners, Inc. Buy 6.42% 3.85%
OMI Owens & Minor, Inc. Buy 7.73% 24.95%
INGN Inogen, Inc. Buy 6.37% 2.92%
ARDX Ardelyx, Inc. Buy 6.17% -0.25%
AMRX Amneal Pharmaceuticals, Inc. Buy 8.28% 0%
ABUS Arbutus Biopharma Corporation Sell -4.14% -2.17%
ANAB AnaptysBio, Inc. Sell -3.64% 10.23%
PCRX Pacira BioSciences, Inc. Sell -4.24% -4.56%
VEEV Veeva Systems Inc. Sell -3.61% 5.67%
AMN AMN Healthcare Services, Inc. Sell -3.35% 2.68%
MNKD MannKind Corporation Sell -3.67% 0%
NVAX Novavax, Inc. Sell -3.67% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MNKD
  • NVAX
  • AMRX
Assets Removed
Asset Action Perf %
CLDX Buy All -19.21%
DNLI Sell All 5.92%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings